Product,EMA,FDA,EN,Other,WHO,Year,Generic,DrugBank ID,ATC,ChEMBL,Indications,Targets,Last Update,ChEMBL_ID,,,,
Abemaciclib,Y,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB12001"">DB12001</a>",L01EF03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301610"">CHEMBL3301610</a>",Advanced Breast Cancer; Metastatic Breast Cancer,CDK6; CDK4; CCND1; CCND3; CDKN2A; NRAS; CCND2; SMARCA4; KRAS,1/2/2022,CHEMBL3301610,,,,
Abiraterone,Y,Y,N,,Y,2011,Y,"<a href=""https://go.drugbank.com/drugs/DB05812"">DB05812</a>",L02BX03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL254328"">CHEMBL254328</a>",Metastatic Castration Resistant Prostate Cancer,CYP17A1; DSE; TSPYL1; PTEN,14/11/2022,CHEMBL254328,,,,
Acalabrutinib,Y,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB11703"">DB11703</a>",L01EL02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3707348"">CHEMBL3707348</a>",Chronic Lymphocytic Leukaemia (CLL); Mantle Cell Lymphoma (MCL); Small Lymphocytic Lymphoma,BTK,22/06/2022,CHEMBL3707348,,,,
Aclarubicin,N,N,N,Japan,N,,,"<a href=""https://go.drugbank.com/drugs/DB11617"">DB11617</a>",L01DB04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL502620"">CHEMBL502620</a>",,SMN1; TOP2B; CSF2,22/09/2020,CHEMBL502620,,,,
Afatinib,Y,Y,N,,Y,2013,N,"<a href=""https://go.drugbank.com/drugs/DB08916"">DB08916</a>",L01EB03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1173655"">CHEMBL1173655</a>","Metastatic Non-Small Cell Lung Cancer; Refractory, metastatic squamous cell Non-small cell lung cancer",EGFR; ERBB2; ERBB4; KRAS; EML4; MET; BRAF; NRG1; NRAS; ERBB3,1/2/2022,CHEMBL1173655,,,,
Aflibercept,Y,Y,N,,N,2011,N,"<a href=""https://go.drugbank.com/drugs/DB08885"">DB08885</a>",S01LA05; L01XX44,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1742982"">CHEMBL1742982</a>",Metastatic Colorectal Cancer (MCRC),VEGFA; VEGFB; PGF; PIGF; VEGFC,17/09/2020,CHEMBL1742982,,,,
Aldesleukin,N,Y,Y,,N,1992,N,"<a href=""https://go.drugbank.com/drugs/DB00041"">DB00041</a>",L03AC01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201438"">CHEMBL1201438</a>",High Risk Neuroblastoma; Metastatic Melanoma; Metastatic Renal Cell Carcinoma,IL2RG; IL2RB; IL2RA; IL2,17/09/2020,CHEMBL1201438,,,,
Alectinib,Y,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB11363"">DB11363</a>",L01ED03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1738797"">CHEMBL1738797</a>","Refractory, metastatic Non small cell lung cancer",ALK; FGFR1; EML4; NPM1; CDKN2A; SMAD4; RET,1/2/2022,CHEMBL1738797,,,,
Alemtuzumab,Y,Y,N,,N,2001,N,"<a href=""https://go.drugbank.com/drugs/DB00087"">DB00087</a>",L04AA34,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201587"">CHEMBL1201587</a>",B-Cell Chronic Lymphocytic Leukemia; T-Cell Prolymphocytic Leukemia,CD52; CXCL12,17/09/2020,CHEMBL1201587,,,,
Alitretinoin,Y,Y,N,,N,1999,N,"<a href=""https://go.drugbank.com/drugs/DB00523"">DB00523</a>",D11AH04; L01XF02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL705"">CHEMBL705</a>",,RXRG; RARA; RXRA; RXRB; RARB; RARG,22/06/2022,CHEMBL705,,,,
Alpelisib,Y,Y,N,,N,2019,N,"<a href=""https://go.drugbank.com/drugs/DB12015"">DB12015</a>",L01EM03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2396661"">CHEMBL2396661</a>",Advanced Metastatic Breast Cancer,PIK3C2B; PIK3R4; PIK3C2A; PIK3R1; PIK3R6; PIK3R3; PIK3CA; PIK3R5; PIK3R2; PIK3C2G; PIK3C3; BRAF; SGK1; PI4KA; RB1; PTEN; CDK4,1/2/2022,CHEMBL2396661,,,,
Altretamine,N,N,Y,,N,1990,N,"<a href=""https://go.drugbank.com/drugs/DB00488"">DB00488</a>",L01XX03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1455"">CHEMBL1455</a>",Ovarian Cancer; Ovarian Cancer Stage III,CYP1A2,1/2/2022,CHEMBL1455,,,,
Aminolevulinic Acid,Y,Y,N,,N,1999,N,"<a href=""https://go.drugbank.com/drugs/DB00855"">DB00855</a>",L01XD04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL601"">CHEMBL601</a>",Basal Cell Carcinoma (BCC); Squamous Cell Carcinoma (SCC),,17/09/2020,CHEMBL601,,,,
Amivantamab,Y,Y,N,,N,2021,N,"<a href=""https://go.drugbank.com/drugs/DB16695"">DB16695</a>",L01FX18,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297774"">CHEMBL4297774</a>","Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer",EGFR; MET,31/01/2022,CHEMBL4297774,,,,
Amrubicin,N,N,N,Japan,N,2002,,"<a href=""https://go.drugbank.com/drugs/DB06263"">DB06263</a>",L01DB10,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1186894"">CHEMBL1186894</a>",,TOP2A,22/09/2020,CHEMBL1186894,,,,
Amsacrine,N,N,N,,N,1987,N,"<a href=""https://go.drugbank.com/drugs/DB00276"">DB00276</a>",L01XX01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL43"">CHEMBL43</a>","Leukemia, Acute; Refractory Leukemia",TOP2A; TOP2B; BTF3P11,1/2/2022,CHEMBL43,,,,
Anastrozole,N,Y,Y,,Y,1995,Y,"<a href=""https://go.drugbank.com/drugs/DB01217"">DB01217</a>",L02BG03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1399"">CHEMBL1399</a>","Advanced Breast Cancer; Early Breast Cancer; Locally Advanced Breast Cancer (LABC); Metastatic Breast Cancer; Invasive, early Breast Cancer",CYP19A1; TUBB1; TNFRSF11B; PGR; MAP4K4; UGT1A4; CYP1B1; IGF2; KMT2C; TNFSF11,14/11/2022,CHEMBL1399,,,,
Apalutamide,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB11901"">DB11901</a>",L02BB05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3183409"">CHEMBL3183409</a>",Nonmetastatic Prostate Cancer,AR,17/09/2020,CHEMBL3183409,,,,
Arsenic Trioxide,Y,Y,N,,Y,2018,Y,"<a href=""https://go.drugbank.com/drugs/DB01169"">DB01169</a>",L01XX27,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200978"">CHEMBL1200978</a>",Refractory Acute Promyelocytic Leukemia,TXNRD1; TXNRD2,14/11/2022,CHEMBL1200978,,,,
Asciminib,Y,Y,N,,N,2021,N,"<a href=""https://go.drugbank.com/drugs/DB12597"">DB12597</a>",L01EA06,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4208229"">CHEMBL4208229</a>",Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase,ABL1,23/10/2022,CHEMBL4208229,,,,
Asparaginase,Y,Y,N,,Y,1994,N,"<a href=""https://go.drugbank.com/drugs/DB00023"">DB00023</a>",L01XX02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108989"">CHEMBL2108989</a>",Acute Lymphoblastic Leukaemias (ALL),CPA2; NOTCH1; LPL; ETV6; ASNS; TYMSOS; GATA3; HLA-DRB1; PYGL; GRIA1; TYMS; NFATC2; PNPLA3; SOD2; RB1,1/2/2022,CHEMBL2108989,,,,
Atezolizumab,Y,Y,N,,N,2016,N,"<a href=""https://go.drugbank.com/drugs/DB11595"">DB11595</a>",L01FF05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3707227"">CHEMBL3707227</a>",Metastatic Non-Small Cell Lung Cancer; Small Cell Lung Cancer (SCLC); Triple Negative Breast Cancer (TNBC); Urothelial carcinoma ureter metastatic; Locally advanced Urothelial Carcinoma,CD274; KRAS; ARID1A; CTLA4; JAK3; MDM4; ALK; STK11; HLA-DRA; CX3CL1; EGFR; PBRM1,1/2/2022,CHEMBL3707227,,,,
Avapritinib,Y,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB15233"">DB15233</a>",L01EX18,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4204794"">CHEMBL4204794</a>",Metastatic Gastrointestinal Stromal Tumor; Unresectable Gastrointestinal stromal tumor,KIT; PDGFRA,17/09/2020,CHEMBL4204794,,,,
Avelumab,Y,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB11945"">DB11945</a>",L01FF04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3833373"">CHEMBL3833373</a>",Locally advanced disease has progressed during or following platinum-containing chemotherapy urothelial carcinoma (UC); Locally advanced disease has progressed within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy urothelial carcinoma (UC); Metastatic Merkel Cell Carcinoma (MCC); Metastatic disease has progressed during or following platinum-containing chemotherapy urothelial carcinoma (UC); Metastatic disease has progressed within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy urothelial carcinoma (UC),CD274; EGFR,1/2/2022,CHEMBL3833373,,,,
Axicabtagene Ciloleucel,Y,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB13915"">DB13915</a>",L01XX70,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989989"">CHEMBL3989989</a>",Refractory Diffuse large B-cell lymphoma NOS; Refractory High grade B-cell lymphoma Burkitt-like lymphoma; Refractory Primary Mediastinal Large B-Cell Lymphoma; Relapsed Diffuse large B-cell lymphoma NOS; Relapsed High grade B-cell lymphoma Burkitt-like lymphoma; Relapsed Primary Mediastinal Large B-Cell Lymphoma,,17/09/2020,CHEMBL3989989,,,,
Axitinib,Y,Y,N,,N,2012,N,"<a href=""https://go.drugbank.com/drugs/DB06626"">DB06626</a>",L01EK01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1289926"">CHEMBL1289926</a>",Advanced Thyroid cancer,FLT1; KDR; PDGFB; KIT; FLT4; PDGFRB; ABL1; UGT1A1; CYP3A5,22/06/2022,CHEMBL1289926,,,,
Azacitidine,Y,Y,N,,N,2004,Y,"<a href=""https://go.drugbank.com/drugs/DB00928"">DB00928</a>",L01BC07,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1489"">CHEMBL1489</a>",Acute Myeloid Leukemia (AML); Chronic Myelomonocytic Leukemia,DNMT1; DNMT3A; GGT1; CD247; AFP; ASXL1; TG; IL11; TAGLN; PLAU; MGMT; LIF; TRIT1; TYMS; GATA2; CDA; TET2,14/11/2022,CHEMBL1489,,,,
BCG Vaccine,Y,Y,N,,Y,,,"<a href=""https://go.drugbank.com/drugs/DB12768"">DB12768</a>",L03AX03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108905"">CHEMBL2108905</a>",Non-Invasive Bladder Urothelial Carcinoma; Recurrent Superficial Bladder Cancer; Urothelial Carcinoma Recurrent; Carcinoma in situ of urinary bladder,,22/09/2020,CHEMBL2108905,,,,
Belantamab Mafodotin,Y,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB15719"">DB15719</a>",L01FX15,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298209"">CHEMBL4298209</a>",Relapsed Or Refractory Multiple Myeloma,,1/2/2022,CHEMBL4298209,,,,
Belinostat,N,Y,N,,N,2014,N,"<a href=""https://go.drugbank.com/drugs/DB05015"">DB05015</a>",L01XH04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL408513"">CHEMBL408513</a>",Relapsed Peripheral T-Cell Lymphoma; Refractory Peripheral T-cell Lymphoma Unspecified,HDAC2; HDAC5; HDAC4; HDAC10; HDAC7; HDAC11; HDAC9; HDAC1; HDAC3; HDAC6; HDAC8; UGT1A1; FBXW7,1/2/2022,CHEMBL408513,,,,
Belotecan,N,N,N,South Korea,N,2003,,"<a href=""https://go.drugbank.com/drugs/DB12459"">DB12459</a>",L01CE04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2111084"">CHEMBL2111084</a>",,,22/09/2020,CHEMBL2111084,,,,
Bendamustine,N,Y,Y,,Y,2008,Y,"<a href=""https://go.drugbank.com/drugs/DB06769"">DB06769</a>",L01AA09,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL487253"">CHEMBL487253</a>",Chronic Lymphocytic Leukaemia (CLL); Follicular Non-Hodgkin&#39;s Lymphoma Refractory; Refractory Hodgkin Lymphoma; Refractory Mantle Cell Lymphoma; Waldenstrom&#39;s Macroglobulinemia (WM); Recurrent multiple myeloma; Refractory indolent B cell non-hodgkin lymphoma,ATM,1/2/2022,CHEMBL487253,,,,
Bevacizumab,Y,Y,N,,Y,2004,N,"<a href=""https://go.drugbank.com/drugs/DB00112"">DB00112</a>",S01LA08; L01FG01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201583"">CHEMBL1201583</a>",Cervical Cancer Metastatic; Metastatic Colorectal Cancer (MCRC); Metastatic Non-Squamous Non-Small Cell Lung Cancer; Metastatic Renal Cell Carcinoma; Persistent Cervical Cancer; Recurrent Cervical Cancer; Recurrent Glioblastoma; Stage III epithelial ovarian cancer following initial surgical resection; Stage IV epithelial ovarian cancer following initial surgical resection; Fallopian tube cancer following initial surgical resection; Locally advanced nonsquamous non-small cell lung cancer; Primary peritoneal cancer following initial surgical resection; Recurrent Non-Squamous Non-Small Cell Lung Cancer; Recurrent Platinum-Sensitive Epithelial Ovarian Cancer; Recurrent Platinum-resistant Epithelial Ovarian Cancer; Recurrent platinum drug resistant Fallopian tube cancer; Recurrent platinum drug resistant primary peritoneal cancer; Recurrent platinum sensitive primary peritoneal cancer; Recurrent platinum-sensitive fallopian tube cancer; Unresectable Non-Squamous Non-Small-Cell Lung Cancer,VEGFA; PRKCA; EDN1; VEGFC; MGAT4A; VEGFB; RGS5; THBS2; ARMS2; SHMT1; CFH; GGH; HSP90AB1; MTHFR; VHL; HRAS; CXCR4; BRAF; GC; MMP9; MMP2; HTRA1,1/2/2022,CHEMBL1201583,,,,
Bexarotene,Y,Y,N,,N,1999,Y,"<a href=""https://go.drugbank.com/drugs/DB00307"">DB00307</a>",L01XF03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1023"">CHEMBL1023</a>",Refractory peripheral cutaneous T-cell lymphoma,RXRG; RXRA; RXRB; NR1H3; MAPK8,14/11/2022,CHEMBL1023,,,,
Bicalutamide,N,Y,Y,,Y,1995,Y,"<a href=""https://go.drugbank.com/drugs/DB01128"">DB01128</a>",L02BB03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL409"">CHEMBL409</a>",Stage D2 Prostatic carcinoma,AR; CFLAR; BAX; CYP2B6; FST; KLK3,1/2/2022,CHEMBL409,,,,
Binimetinib,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB11967"">DB11967</a>",L01EE03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3187723"">CHEMBL3187723</a>",Metastatic Melanoma; Unresectable Melanoma,MAP2K1; MAP2K3; MAP2K2; MAP2K5; MAP2K6; MAP2K7; MAP2K4; BRAF; NF1; KRAS; APC; ATM; PTEN; GNAQ; UGT1A1; NRAS; GNA11; HRAS,1/2/2022,CHEMBL3187723,,,,
Bleomycin,N,Y,Y,,Y,1973,Y,"<a href=""https://go.drugbank.com/drugs/DB00290"">DB00290</a>",L01DC01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL403664"">CHEMBL403664</a>","Cervical Cancers; Head and Neck Carcinoma; Intracranial Germ Cell Tumors; Lymphoma, Hodgkins; Malignant Pleural Effusions; Non-Hodgkin&#39;s Lymphoma (NHL); Ovarian Cancer; Penile Cancer; Testicular Cancer; Vulvar Cancers; Early Kaposi&#39;s sarcoma",LIG1; F2R; CTLA4; GJA1; MAPK8; AFP; ADK; ERCC2; GSTM1; CCL17; SMAD2; ERCC1; IFNG,1/2/2022,CHEMBL403664,,,,
Blinatumomab,Y,Y,N,,N,2014,N,"<a href=""https://go.drugbank.com/drugs/DB09052"">DB09052</a>",L01FX07,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1742992"">CHEMBL1742992</a>",Precursor B-Lymphoblastic Lymphoma/Leukaemia Refractory; Relapsed B cell precursor Acute lymphoblastic leukemia,CD19; CD3E; CD3D; BCR; ABL1; CD247; CD3G,1/2/2022,CHEMBL1742992,,,,
Bortezomib,Y,Y,N,,Y,2003,Y,"<a href=""https://go.drugbank.com/drugs/DB00188"">DB00188</a>",L01XG01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL325041"">CHEMBL325041</a>",Mantle Cell Lymphoma (MCL); Multiple Myeloma (MM),PSMC2; PSMD4P1; PSMD11; PSMB3; PSMD3; PSMA8; PSMB10; PSMC3IP; PSMD14; PSMD8; PSMD13; PSMC1P1; PSMD10P2; PSME3; PSMB1; PSMD9; PSMD10P3; PSMD6; PSMD12; PSMC3; PSME2P2; PSMA1; PSMD4; PSMC4; PSMB8; PSMD2; PSME1; PSMD10; PSMD5; PSMA6; PSMD1; PSMA3; PSME2; PSMA4; PSMC5; PSMC1; PSMB6; PSMB5; PSMB4; PSMB9; PSME4; PSMA2; PSMB7; PSMD7; PSMB2; PSMB11; PSMA7; ADRM1; PSMA5; PSMF1; PSMC6; PIPSL; PSMD10P1; SEM1; BCL2L2; PRSS1; PMAIP1; CTSB; KLK4; PRSS3; F12; PRSS2; GATA2; CAPN1; HSPB2; PRB2; PLAT; CTSL,14/11/2022,CHEMBL325041,,,,
Bosutinib,Y,Y,N,,N,2010,N,"<a href=""https://go.drugbank.com/drugs/DB06616"">DB06616</a>",L01EA04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL288441"">CHEMBL288441</a>","Refractory, accelerated phase Chronic myelogenous leukemia; Refractory, blast phase Chronic myelogenous leukemia; Refractory, chronic phase Chronic myelogenous leukemia",HCK; ABL1; SRC; LYN; BCR; EGFR,22/06/2022,CHEMBL288441,,,,
Brentuximab vedotin,Y,Y,N,,N,2011,N,"<a href=""https://go.drugbank.com/drugs/DB08870"">DB08870</a>",L01FX05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1742994"">CHEMBL1742994</a>",B-large cell anaplastic Lymphoma (Kiel Classification) refractory; Refractory Hodgkin Lymphoma; Post-autologous hematopoietic stem cell transplantation Hodgkin lymphoma,TUBB2B; TUBB8; TUBB6; TUBA4A; TUBB3; TUBB2A; TUBA3E; TUBA1C; TUBA1A; TUBA1B; TUBB4B; TNFRSF8; TUBA3D,1/2/2022,CHEMBL1742994,,,,
Brigatinib,Y,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB12267"">DB12267</a>",L01ED04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545311"">CHEMBL3545311</a>",Metastatic Non-Small Cell Lung Cancer,ALK; EGFR; ROS1,22/06/2022,CHEMBL3545311,,,,
Buserelin,N,N,Y,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB06719"">DB06719</a>",L02AE01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110824"">CHEMBL2110824</a>",Stage D2 Prostatic carcinoma,GNRHR; IGFBP1,22/09/2002,CHEMBL2110824,,,,
Busulfan,Y,Y,N,,N,1954,Y,"<a href=""https://go.drugbank.com/drugs/DB01008"">DB01008</a>",L01AB01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL820"">CHEMBL820</a>",Essential Thrombocythemia (ET); Polycythemia Vera (PV); Chronic Chronic myelogenous leukemia,GSTA1; THPO; BCR; GSTM1; GALC; ITGAL; CTH; GSTP1; CYP2B6; ADK; G6PD; ABL1,1/2/2022,CHEMBL820,,,,
Cabazitaxel,Y,Y,N,,N,2010,N,"<a href=""https://go.drugbank.com/drugs/DB06772"">DB06772</a>",L01CD04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201748"">CHEMBL1201748</a>","Refractory, metastatic hormone-refractory Prostate cancer",TUBB1; TUBA4A; IGF2; TUB,22/06/2022,CHEMBL1201748,,,,
Cabozantinib,Y,Y,N,,N,2012,N,"<a href=""https://go.drugbank.com/drugs/DB08875"">DB08875</a>",L01EX07,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105717"">CHEMBL2105717</a>","Advanced Renal Cell Carcinoma; Hepatocellular Carcinoma; Metastatic Clear Cell Renal Cell Carcinoma; Progressive, metastatic Medullary thyroid cancer",RET; KDR; MET; FLT3; KIT; TEK; GNA11; CFLAR; ROS1; HRAS,1/2/2022,CHEMBL2105717,,,,
Calaspargase Pegol,N,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB14730"">DB14730</a>",,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108728"">CHEMBL2108728</a>",Acute Lymphoblastic Leukaemias (ALL),,17/09/2020,CHEMBL2108728,,,,
Capecitabine,Y,Y,N,,Y,1998,Y,"<a href=""https://go.drugbank.com/drugs/DB01101"">DB01101</a>",L01BC06,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1773"">CHEMBL1773</a>","Duke&#39;s C Colon cancer; Esophageal Cancers; Hepatobiliary Cancers; Malignant Neoplasm of Stomach; Metastatic Breast Cancer; Metastatic Colorectal Carcinoma; Pancreatic Cancer Metastatic; Refractory Fallopian Tube Carcinoma; Metastatic pancreatic endocrine carcinoma; Refractory Ovarian cancer; Refractory peritoneal cancer; Refractory, metastatic Colorectal carcinoma",TYMS; MGAT4A; DLG5; CDH1; DPYD; VEGFA; CYP1A1; MTHFR; UMPS; EXO1; AREG; MIR2054; MIR27A; ADCY2; CES1P1; TYMP; CDA; ERBB2; ERCC1; SELE; ENOSF1; CES1; HLA-G; TYMSOS; SLC22A7; REV3L,14/11/2022,CHEMBL1773,,,,
Capmatinib,Y,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB11791"">DB11791</a>",L01EX17,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3188267"">CHEMBL3188267</a>",Metastatic Non-Small Cell Lung Cancer,MET; EGFR; BRAF,22/06/2022,CHEMBL3188267,,,,
Carboplatin,N,Y,Y,,Y,1989,Y,"<a href=""https://go.drugbank.com/drugs/DB00958"">DB00958</a>",L01XA02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1351"">CHEMBL1351</a>",Advanced Cervical Cancer; Advanced Endometrial Cancer; Advanced Esophageal Cancers; Advanced Head and Neck Cancer; Advanced Melanoma; Advanced Non Small Cell Lung Cancer; Advanced Ovarian Carcinoma; Advanced Sarcoma; Metastatic Breast Cancer; Neuroendocrine Carcinoma of the Skin; Pleural mesothelioma malignant; Refractory Hodgkin Lymphoma; Retinoblastoma; Advanced Bladder cancer; Advanced Small cell lung cancer; Advanced Testicular cancer; Advanced Thymoma; Advanced thymic carcinoma; Refractory Non-Hodgkin&#39;s lymphoma,GCLC; ATP7A; GPX5; PRRC2A; XRCC1; TP73; SOX10; C6ORF15; EIF3A; ACSS2; ERCC1; MTHFR; DOCK8; MAP3K1; HLA-C; FNTB; DSCAM; MSH5; SLC31A1; TRIM5; MAD1L1; ATP7B; ATAT1; SMAD4; SERPINA5; ETS2; MUCL3; XYLT2; PSORS1C1; NF2; ERCC2; CDSN; MTR; BARD1; RNF8; GSR; SLCO1B3; PPP1R18; SLC19A1; HCP5,14/11/2022,CHEMBL1351,,,,
Carfilzomib,Y,Y,N,,N,2009,N,"<a href=""https://go.drugbank.com/drugs/DB08889"">DB08889</a>",L01XG02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL451887"">CHEMBL451887</a>",Refractory Multiple Myeloma; Waldenstrom&#39;s Macroglobulinemia (WM),PSMB2; PSMD14; PSMB8; PSMD13; PSMC6; PSMC5; PSMA6; PSMD6; PSMC1; PSMA5; PSME2; PSMA2; PSMB5; PSMA3; PSMD10P2; PSMB9; PSMD3; PSMB7; PIPSL; PSMA7; PSMB4; PSMD4; SEM1; PSMC3; PSMB6; PSMD2; PSMD7; PSMD12; PSMC4; PSMB10; PSMA1; PSMD5; PSMD8; PSMC2; PSMB11; PSMA4; PSMD11; PSMD1; PSMB1; ADRM1; PSMA8; PSMB3; PSME1; PSMD10P3; PSME2P2; PSMD4P1; PSMC1P1; PSME4; PSME3; PSMD10; PSMD10P1; PSMF1; PSMD9; PSMC3IP; PRB2,17/09/2020,CHEMBL451887,,,,
Carmofur,N,N,N,Japan,N,,,"<a href=""https://go.drugbank.com/drugs/DB09010"">DB09010</a>",L01BC04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL460499"">CHEMBL460499</a>",,,28/10/2021,CHEMBL460499,,,,
Carmustine,Y,Y,N,,N,1977,Y,"<a href=""https://go.drugbank.com/drugs/DB00262"">DB00262</a>",L01AD01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL513"">CHEMBL513</a>",Astrocytomas; Brain Stem Gliomas; Ependymomas; Glioblastomas; Medulloblastomas; Mycosis Fungoides (MF); Recurrent Glioblastoma Multiforme; Refractory Hodgkin Lymphoma; Refractory Multiple Myeloma; Tumors Metastatic to Brain; High grade newly diagnosed Glioma; Refractory Non-Hodgkin&#39;s lymphoma,GSR; G6PD; MGMT; PLAU; E2F1,14/11/2022,CHEMBL513,,,,
Carmustine Implant,Y,Y,N,,N,1977,Y,"<a href=""https://go.drugbank.com/drugs/DB00262"">DB00262</a>",L01AD01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL513"">CHEMBL513</a>",Astrocytomas; Brain Stem Gliomas; Ependymomas; Glioblastomas; Medulloblastomas; Mycosis Fungoides (MF); Recurrent Glioblastoma Multiforme; Refractory Hodgkin Lymphoma; Refractory Multiple Myeloma; Tumors Metastatic to Brain; High grade newly diagnosed Glioma; Refractory Non-Hodgkin&#39;s lymphoma,GSR; G6PD; MGMT; PLAU; E2F1,14/11/2022,CHEMBL513,,,,
Cemiplimab,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB14707"">DB14707</a>",L01FF06,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297723"">CHEMBL4297723</a>","Metastatic cutaneous squamous cell carcinoma; Locally advanced cutaneous squamous cell carcinoma, and not a candidate for curative surgery or curative radiation",PDCD1; CDK12,1/2/2022,CHEMBL4297723,,,,
Ceritinib,Y,Y,N,,N,2014,N,"<a href=""https://go.drugbank.com/drugs/DB09063"">DB09063</a>",L01ED02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2403108"">CHEMBL2403108</a>","Refractory, locally advanced Non-small cell lung cancer; Refractory, metastatic Non small cell lung cancer",IGF1R; ALK; INSR; TSSK1B; SRC; MAP2K1; EML4; ROS1; NPM1,1/2/2022,CHEMBL2403108,,,,
Cetuximab,Y,Y,N,,N,2004,N,"<a href=""https://go.drugbank.com/drugs/DB00002"">DB00002</a>",L01FE01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201577"">CHEMBL1201577</a>",Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN); Metastatic Colorectal Cancer (MCRC); Metastatic Squamous Cell Carcinoma of the Head and Neck; Recurrent Squamous Cell Carcinoma of the Head or Neck; Regionally Advanced Squamous Cell Carcinoma of the Head and Neck,EGFR; CCND1; MGAT4A; NRAS; FCGR3A; HBEGF; NT5E; ERBB3; NRG2; BTC; FCGR2A; AREG; MAP2K1; SMAD4; DNTT; BRAF; NRG3; RARA; NRG1; CXCL8; EGF; HNF4A; GC; TGFA; VPS37A; EREG; PIK3CA; EPO; KRAS; PTP4A3,1/2/2022,CHEMBL1201577,,,,
Chlorambucil,N,Y,Y,,Y,1957,N,"<a href=""https://go.drugbank.com/drugs/DB00291"">DB00291</a>",L01AA02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL515"">CHEMBL515</a>",Chronic Lymphocytic Leukaemia (CLL); Hodgkins Disease (HD); Non-Hodgkin&#39;s Lymphoma (NHL); Waldenstrom&#39;s Macroglobulinemia (WM); Giant follicular lymphoma,BRCA1; MGMT; GFER; CXCL12; GSTM1; BRCA2; FANCC,1/2/2022,CHEMBL515,,,,
Chlormethine,Y,Y,N,,N,1949,N,"<a href=""https://go.drugbank.com/drugs/DB00888"">DB00888</a>",L01AA05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL427"">CHEMBL427</a>","Carcinoma, Bronchogenic; Chronic Lymphocytic Leukaemia (CLL); Hodgkins Disease (HD); Lymphoma, Diffuse; Mycosis Fungoides (MF); Polycythemia Vera (PV); Stage I Mycosis Fungoides; Malignant effusion",CSF2,17/09/2020,CHEMBL427,,,,
Ciltacabtagene Autoleucel,Y,Y,N,,N,2022,N,"<a href=""https://go.drugbank.com/drugs/DB16738"">DB16738</a>",L01XL05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4802263"">CHEMBL4802263</a>","Refractory Multiple Myeloma, Relapsed Multiple Myeloma",,23/10/2022,CHEMBL4802263,,,,
Cisplatin,N,Y,Y,,Y,1978,Y,"<a href=""https://go.drugbank.com/drugs/DB00515"">DB00515</a>",L01XA01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2068237"">CHEMBL2068237</a>; <a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL11359"">CHEMBL11359</a>","Advanced Pancreatic Cancer; Breast Cancer; Cervical Cancers; Esophageal Cancers; Head and Neck Carcinoma; Hepatobiliary Cancers; Hepatoblastomas; Malignant Neoplasm of Stomach; Medulloblastomas; Metastatic Melanoma; Multiple Myeloma (MM); Neuroblastomas; Non-Small Cell Lung Carcinoma (NSCLC); Ovarian Cancer Metastatic; Pleural Mesotheliomas; Primary Central Nervous System Lymphoma (PCNSL); Recurrent Endometrial Cancer; Refractory Hodgkin Lymphoma; Sarcoma, Osteogenic; Small Cell Lung Cancer (SCLC); Thymic Cancer; Advanced Bladder cancer; Metastatic Anal cancer; Metastatic Endometrial cancer; Metastatic Penile cancer; Metastatic Testicular cancer; Refractory Non-Hodgkin&#39;s lymphoma",ERCC2; POLR1G; GADD45A; ACYP2; SLC22A2; CMPK1; MDH2; GCLM; STAT1; CSNK2A3; RARS1; FANCA; UBE2I; REV3L; HMGB1; LRP2; LIG3; XRCC5; REV1; ERCC1; MIR21; GPX5; COMT; H2AW; MTHFR; OTOS; KLC3; DRAM1; GCLC; SMARCA4; BIRC7; AQP9; DCBLD1; GALNT18; XPC; GABPA; MT1F; BRCA2; DFFB; ATR; ADH1C; NF2; MAP3K1; GRP; ATP7B; PPP1R13L; GALNT14; MUTYH; EPHX1; GSTP1; EIF3A; RRM1; MLLT3; MTR; LIF; TP73; KRT20; TERC; MT1H; FXN; SLC31A1; ACSS2; CDH17; FANCC; CDC25C; SLC16A5,22/06/2022,CHEMBL2068237,,,,CHEMBL11359</a
Cladribine,Y,Y,N,,N,1993,Y,"<a href=""https://go.drugbank.com/drugs/DB00242"">DB00242</a>",L04AA40; L01BB04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1619"">CHEMBL1619</a>",Chronic Lymphocytic Leukaemia (CLL); Cutaneous T-Cell Lymphoma (CTCL); Hairy Cell Leukemia (HCL); Non-Hodgkin&#39;s Lymphoma (NHL),RRM2B; RRM1; RRM2; DIABLO; NT5C1A; XIAP; DCK; BCL2L2; TGFB1; ADA; CDKN1A; IL2RA,17/09/2020,CHEMBL1619,,,,
Clofarabine,Y,Y,N,,N,2004,Y,"<a href=""https://go.drugbank.com/drugs/DB00631"">DB00631</a>",L01BB06,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1750"">CHEMBL1750</a>",Acute Lymphoblastic Leukaemia Recurrent; Refractory Acute Lymphoblastic Leukemia; Refractory Acute Myelogenous Leukemia (AML); Refractory Langerhans cell histiocytosis,POLA1; RRM1; RRM2; POLE; RRM2B; POLD1; APBB1,14/11/2022,CHEMBL1750,,,,
Cobimetinib,Y,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB05239"">DB05239</a>",L01EE02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2146883"">CHEMBL2146883</a>",Metastatic Melanoma; Unresectable Melanoma,MAP2K1; MAP2K7; MAP2K2; MAP2K6; MAP2K3; MAP2K4; MAP2K5; RAF1; ARAF; BRAF; KRAS; NF1,1/2/2022,CHEMBL2146883,,,,
Copanlisib,N,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB12483"">DB12483</a>",L01EM02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3218576"">CHEMBL3218576</a>",Relapsed Follicular Lymphoma,PIK3C2B; PIK3CD; PIK3C2A; PIK3R6; PIK3R3; PIK3CA; PIK3CG; PIK3R1; PIK3R2; PIK3CB; PIK3R5; PIK3C2G; PIK3R4; PIK3C3; PTEN,1/2/2022,CHEMBL3218576,,,,
Crizotinib,Y,Y,N,,N,2011,N,"<a href=""https://go.drugbank.com/drugs/DB08865"">DB08865</a>",L01ED01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL601719"">CHEMBL601719</a>",Metastatic Non-Small Cell Lung Cancer,MET; ROS1; ALK; EML4; NPM1; ETV6; PTPN12; SMAD4; AREG; EGFR; CDKN2A; NTRK1; KRAS,1/2/2022,CHEMBL601719,,,,
Cyclophosphamide,N,Y,Y,,Y,1959,Y,"<a href=""https://go.drugbank.com/drugs/DB00531"">DB00531</a>",L01AA01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL88"">CHEMBL88</a>","Acute Lymphoblastic Leukaemias (ALL); Acute Myelocytic Leukemia; Adenocarcinoma of the Ovaries; Breast Cancer; Burkitt&#39;s Lymphoma; Chronic Lymphocytic Leukaemia (CLL); Chronic Myeloid Leukemia (CML); Disseminated Neuroblastoma; Ewing&#39;s Sarcoma; Lung Cancers; Lymphoma, Hodgkins; Multiple Myeloma (MM); Non-Hodgkin&#39;s Lymphoma (NHL); Ovarian germ cell tumour; Pheochromocytomas; Retinoblastoma; Rhabdomyosarcomas; Waldenstrom&#39;s Macroglobulinemia (WM); Advanced Alibert-Bazin syndrome; Histiocytic lymphoma; Metastatic gestational trophoblastic tumor; Mixed-cell type lymphoma; Refractory Small cell lung cancer; Relapsed Wilm&#39;s tumor",SLC22A16; NOS3; QUINONE REDUCTASE 2; GNL3; XRCC1; ERCC1; CYP2A6; IL5; CYP2B6; TP53AIP1; PNPLA3; DROSHA; LINC00251; BMP7; MUTYH; CBR1; CBR3; LIG3; ALDH3A1; IRS1; HMMR; PERP; ACTB; GSTP1; CXCL12; PPP2R5D; DOK5; SOD2; CCNK; NTF3; RBX1; TPMT; EPHX1; TNFRSF1A; GSTA1; ADH1C; FOXO1; MYCN; CTH; NAT2; GATA3,1/2/2022,CHEMBL88,,,,
Cytarabine,Y,Y,N,,Y,1969,Y,"<a href=""https://go.drugbank.com/drugs/DB00987"">DB00987</a>",L01BC01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL803"">CHEMBL803</a>",Acute Lymphocytic Leukemia (ALL); Acute Myeloid Leukemia (AML); Acute Promyelocytic Leukemia (APL); Leptomeningeal Metastases; Meningeal leukemia; Non-Hodgkin&#39;s Lymphoma (NHL); Blast phase Chronic myelocytic leukemia,POLE; POLA1; POLD1; SLC22A12; DROSHA; CYP2E1; RRM2B; NT5C2; GATA1; GATA3; ABCC4; IKZF1; NT5C3A; RRM2; WT1; NCOA3; DCK; TYMSOS; MED12L; LINC00251; RRM1; CDA; DOK5; P2RY12; BMP7; SULT2B1,14/11/2022,CHEMBL803,,,,
Dabrafenib,Y,Y,N,,N,2013,N,"<a href=""https://go.drugbank.com/drugs/DB08912"">DB08912</a>",L01EC02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2028663"">CHEMBL2028663</a>",Metastatic Melanoma; Unresectable Melanoma,BRAF; CDKN2A; HLA-DRB1; STAG2; NRAS; ATXN1L; MITF; EZH2; MAP2K2; RAC1; MAP2K1; HRAS; NF1,1/2/2022,CHEMBL2028663,,,,
Dacarbazine,N,Y,Y,,Y,1975,Y,"<a href=""https://go.drugbank.com/drugs/DB00851"">DB00851</a>",L01AX04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL476"">CHEMBL476</a>","Advanced Soft Tissue Sarcoma; Lymphoma, Hodgkins; Metastatic Melanoma; Pheochromocytomas; Advanced Medullary thyroid cancer; Advanced Pancreatic neuroendocrine tumor",POLA2; PLAU; ADK; BAX; MGMT; CYP1A1; GSTM1,17/09/2020,CHEMBL476,,,,
Dacomitinib,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB11963"">DB11963</a>",L01EB07,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110732"">CHEMBL2110732</a>; <a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105719"">CHEMBL2105719</a>",Metastatic Non-Small Cell Lung Cancer,EGFR; ERBB3; ERBB4; ERBB2; PTEN,17/09/2020,CHEMBL2110732,,,,CHEMBL2105719</a
Dactinomycin,N,Y,N,,Y,1964,Y,"<a href=""https://go.drugbank.com/drugs/DB00970"">DB00970</a>",L01DA01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1554"">CHEMBL1554</a>","Ewing&#39;s Sarcoma; Ovarian Cancer; Rhabdomyosarcomas; Sarcoma, Osteogenic; Wilms&#39; tumor; Metastatic nonseminomatous Testicular cancer",,14/11/2022,CHEMBL1554,,,,
Daratumumab,Y,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB09331"">DB09331</a>",L01FC01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743007"">CHEMBL1743007</a>",Multiple Myeloma (MM); Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Relapsed Or Refractory Multiple Myeloma,CD38,1/2/2022,CHEMBL1743007,,,,
"Daratumumab, Hyaluronidase",N,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB09331"">DB09331</a>",L01XC24,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743007"">CHEMBL1743007</a>",Multiple Myeloma (MM); Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Relapsed Or Refractory Multiple Myeloma,CD38,17/09/2020,CHEMBL1743007,,,,
Darolutamide,Y,Y,N,,N,2019,N,"<a href=""https://go.drugbank.com/drugs/DB12941"">DB12941</a>",L02BB06,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297185"">CHEMBL4297185</a>",Non-mestatatic castrate-resistant prostate cancer,AR,17/09/2020,CHEMBL4297185,,,,
Dasatinib,Y,Y,N,,Y,2006,Y,"<a href=""https://go.drugbank.com/drugs/DB01254"">DB01254</a>",L01EA02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1421"">CHEMBL1421</a>",Acute Lymphoblastic Leukaemias (ALL); Chronic Myeloid Leukemia (CML),ABL2; BRAF; HCK; KIT; PDGFRB; SRC; EPHA2; FGR; FYN; ABL1; BCR; LCK; SIK2; STAT5B; DDR2; SRMS; ABI1; TEC; PTK6; CRKL; ARID1A; FES; PDGFRA; CBL; MAP3K10; MAP3K20; CDC42BPA; IDH2,22/06/2022,CHEMBL1421,,,,
Daunorubicin,N,Y,Y,,Y,1979,Y,"<a href=""https://go.drugbank.com/drugs/DB00694"">DB00694</a>",L01DB02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL178"">CHEMBL178</a>",Acute Lymphocytic Leukemia (ALL); Acute Myeloid Leukemia (AML); Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute erythroid leukemia; Acute monocytic leukaemia; Newly diagnosed Therapy-Related Acute Myeloid Leukemia,ATP7B; DCK; AKR1C3; BMP7; CBR1; SETD4; GATA1; RPSA; NRP2; LINC00251; FMO3; WT1; DOK5; GATA3; FAS; DROSHA; CBR3; IKZF1; PNPLA3; SLC28A3; AKR1C4; AKR7A2,1/2/2022,CHEMBL178,,,,
Decitabine,Y,Y,N,,N,2006,Y,"<a href=""https://go.drugbank.com/drugs/DB01262"">DB01262</a>",L01BC08,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201129"">CHEMBL1201129</a>",Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes (MDS),DNMT1; DNMT3A; ASXL1; GSTP1; IL2RA; MUC2; TET2,14/11/2022,CHEMBL1201129,,,,
"Decitabine, Cedazuridine",N,Y,N,,N,2006,Y,"<a href=""https://go.drugbank.com/drugs/DB01262"">DB01262</a>",L01BC08,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201129"">CHEMBL1201129</a>",Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes (MDS),DNMT1; DNMT3A; ASXL1; GSTP1; IL2RA; MUC2; TET2,14/11/2022,CHEMBL1201129,,,,
Degarelix,Y,Y,N,,N,2008,N,"<a href=""https://go.drugbank.com/drugs/DB06699"">DB06699</a>",L02BX02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL415606"">CHEMBL415606</a>",Advanced Prostate Cancer,GNRHR; GNRHR2,17/09/2020,CHEMBL415606,,,,
Denileukin Diftitox,N,Y,N,,N,1999,N,"<a href=""https://go.drugbank.com/drugs/DB00004"">DB00004</a>",L01XX29,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201550"">CHEMBL1201550</a>",Cutaneous T-Cell Lymphoma (CTCL),EEF2; IL2RB; IL2RA; IL2RG,17/09/2020,CHEMBL1201550,,,,
Denosumab,Y,Y,N,,N,2010,N,"<a href=""https://go.drugbank.com/drugs/DB06643"">DB06643</a>",M05BX04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1237023"">CHEMBL1237023</a>",Giant cell tumor of the bone; Refractory Hypercalcemia of malignancy,TNFSF11; BRCA1,17/09/2020,CHEMBL1237023,,,,
Dexamethasone,Y,Y,N,,Y,1958,Y,"<a href=""https://go.drugbank.com/drugs/DB01234"">DB01234</a>",S03BA01; S02BA06; S01CB01; S01BA01; R01AD03; H02AB02; D10AA03; D07XB05; D07AB19; C05AA09; A01AC02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL384467"">CHEMBL384467</a>","Leukemia, Acute; Malignant Lymphomas; Multiple Myeloma (MM); Mycosis Fungoides (MF)",ANXA1; IGFBP1; CCL17; CHKA; TDO2; THRSP; RPS19; FOLR1; CDH17; LOH19CR1; UBR1; SAG; BMP7; TJP1; S100A10; GATA3; DOK5; CARTPT; SI; SDS; PYGL; NPPC; TEAD1; JUNB; PZP; SFTPA1; TSC22D3; DPEP1; IRS2; VCAM1; NR5A1; LINC00251; CD86; SOAT1; LIF; MT1F; CHAT; ACTC1; PTH1R; CDK4; TGFBR3; HYAL2; KRT19; HSPA8; F9; FABP1; CRISPLD2,14/11/2022,CHEMBL384467,,,,
Dexrazoxane,Y,Y,N,,N,1995,Y,"<a href=""https://go.drugbank.com/drugs/DB00380"">DB00380</a>",V03AF02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1738"">CHEMBL1738</a>",,TOP2A; MAPK8; CP; ABCB1; TOP2B; DPYS,14/11/2022,CHEMBL1738,,,,
Diethylstilbestrol,N,N,Y,,N,1973,N,"<a href=""https://go.drugbank.com/drugs/DB00255"">DB00255</a>",G03CC05; G03CB02; L02AA01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL411"">CHEMBL411</a>",,ESRRG; ESR1; ESRRB; CP; E2F1; PTGES3; LPO; DNMT1; AMH; MYC; NPPC; BCL2; WNT7A; HRAS,1/2/2022,CHEMBL411,,,,
Dinutuximab,Y,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB09077"">DB09077</a>",L01XC16,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3137342"">CHEMBL3137342</a>",High Risk Neuroblastoma,B4GALNT1; MYCN,17/09/2020,CHEMBL3137342,,,,
Docetaxel,Y,Y,N,,Y,1996,Y,"<a href=""https://go.drugbank.com/drugs/DB01248"">DB01248</a>",L01CD02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL92"">CHEMBL92</a>","Esophageal Cancers; Ewing&#39;s Sarcoma; Locally Advanced Breast Cancer (LABC); Metastatic Bladder Cancer; Metastatic Breast Cancer; Metastatic Hormone Refractory Prostate Cancer; Node Positive Breast Cancer; Ovarian Cancer Metastatic; Small Cell Lung Cancer (SCLC); Soft Tissue Sarcoma (STS); Advanced untreated gastric adenocarcinoma; Locally advanced Squamous cell carcinoma of head and neck; Locally advanced untreated non small cell lung cancer; Metastatic Squamous cell carcinoma of head and neck; Metastatic untreated non small cell lung cancer; Refractory, locally advanced Non small cell lung cancer; Refractory, metastatic Non small cell lung cancer",TUBA3D; TUBA4A; TUBA1B; TUBA3E; TUBB8; TUBB2B; TUBB4B; TUBA1A; TUBA1C; TUBB3; TUBB6; TUBB2A; FOLH1; SLC10A2; EPHX1; RRM1; CYP4B1; IGF2; PGP; BRD4; SOX10; XRCC1; PPCDC; ERCC2; KLK3; BARD1; ATP7A; HNF4A; SPG7; XRCC4; TLE3; RNF8; ORM2; MAP3K1; BCL2; SULT1C4; RPL13; CHST3; MUC16; SNORD68; NR1I3; SLCO1B3; MDM4; VAC14; ABCC6; FBXW7; ACSS2; AKR1C3; PRDX4; GAS6,14/11/2022,CHEMBL92,,,,
Dostarlimab,Y,Y,N,,N,2021,N,"<a href=""https://go.drugbank.com/drugs/DB15627"">DB15627</a>",L01FF07,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298124"">CHEMBL4298124</a>",Adults with mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing regimen,PDCD1,1/2/2022,CHEMBL4298124,,,,
Doxorubicin,N,Y,Y,,Y,1974,Y,"<a href=""https://go.drugbank.com/drugs/DB00997"">DB00997</a>",L01DB01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL53463"">CHEMBL53463</a>","Acute Lymphoblastic Leukaemias (ALL); Acute Myeloblastic Leukemia; Advanced Endometrial Cancer; Advanced Soft Tissue Sarcoma; Bladder transitional cell carcinoma; Carcinoma, Bronchogenic; Gastric Carcinoma; Kaposi&#39;s Sarcoma AIDS Related; Lymphoma, Hodgkins; Malignant Lymphomas; Metastatic Breast Cancer; Multiple Myeloma (MM); Mycosis Fungoides (MF); Neuroblastomas; Ovarian Cancer Metastatic; Ovarian Carcinoma; Sarcoma, Bone; Sezary Syndrome; Soft Tissue Sarcoma (STS); Thyroid Carcinoma; Waldenstrom&#39;s Macroglobulinemia (WM); Wilms&#39; tumor; Advanced Thymoma; Advanced uterine sarcoma",TOP2A; ATRX; AFP; ZEB1; MYB; NOS3; NCF4; RPSA; LRP1B; CYBA; GADD45A; PPM1D; EZH2; QUINONE REDUCTASE 2; TAF1; RAC2; SLC28A3; AKR1A1; SLC22A16; MYOD1; EDN1; GSTA1; CBR3; SDHB; LINC00251; H2AX; DOK5; ALDH3A1; GATA3; AKR1C3; CDKN1B; AKR7A2; IL11; CBR1; SP3; SETD4; BMP7,22/06/2022,CHEMBL53463,,,,
Doxorubicin Liposome,Y,Y,N,,N,1998,Y,"<a href=""https://go.drugbank.com/drugs/Not found in DrugBank"">Not found in DrugBank</a>",L01DB01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL53463"">CHEMBL53463</a>","Acute Lymphoblastic Leukaemias (ALL); Acute Myeloblastic Leukemia; Advanced Endometrial Cancer; Advanced Soft Tissue Sarcoma; Bladder transitional cell carcinoma; Carcinoma, Bronchogenic; Gastric Carcinoma; Kaposi&#39;s Sarcoma AIDS Related; Lymphoma, Hodgkins; Malignant Lymphomas; Metastatic Breast Cancer; Multiple Myeloma (MM); Mycosis Fungoides (MF); Neuroblastomas; Ovarian Cancer Metastatic; Ovarian Carcinoma; Sarcoma, Bone; Sezary Syndrome; Soft Tissue Sarcoma (STS); Thyroid Carcinoma; Waldenstrom&#39;s Macroglobulinemia (WM); Wilms&#39; tumor; Advanced Thymoma; Advanced uterine sarcoma",TOP2A; ATRX; AFP; ZEB1; MYB; NOS3; NCF4; RPSA; LRP1B; CYBA; GADD45A; PPM1D; EZH2; QUINONE REDUCTASE 2; TAF1; RAC2; SLC28A3; AKR1A1; SLC22A16; MYOD1; EDN1; GSTA1; CBR3; SDHB; LINC00251; H2AX; DOK5; ALDH3A1; GATA3; AKR1C3; CDKN1B; AKR7A2; IL11; CBR1; SP3; SETD4; BMP7,22/06/2022,CHEMBL53463,,,,
Durvalumab,Y,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB11714"">DB11714</a>",L01FF03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301587"">CHEMBL3301587</a>","Unresectable Stage III Non-small Cell Lung Cancer; Urothelial carcinoma ureter metastatic; Locally advanced Urothelial Carcinoma; Unresectable, locally advanced PD-L1 positive Lung Cancer Non-Small Cell Cancer (NSCLC)",CD274; MSH2; PBRM1; EGFR; MSH6; ALK,1/2/2022,CHEMBL3301587,,,,
Duvelisib,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB11952"">DB11952</a>",L01EM04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3039502"">CHEMBL3039502</a>","Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL); Relapsed or Refractory Follicular Lymphoma; Refractory, relapsed small lymphocytic lymphoma",PIK3CD; PIK3CG,22/06/2022,CHEMBL3039502,,,,
Edotreotide,Y,N,N,,N,2019,N,"<a href=""https://go.drugbank.com/drugs/DB15494"">DB15494</a>",V09IX09,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL408350"">CHEMBL408350</a>",Neuroendocrine Tumors,,22/06/2022,CHEMBL408350,,,,
Elotuzumab,Y,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB06317"">DB06317</a>",L01FX08,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743010"">CHEMBL1743010</a>",Refractory Multiple Myeloma,SLAMF7,1/2/2022,CHEMBL1743010,,,,
Emapalumab,N,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB14724"">DB14724</a>",L04AA39,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989977"">CHEMBL3989977</a>",,IFNG; SH2D1A; RAB27A; PRF1; UNC13D; XIAP; STX11; STXBP2,17/09/2020,CHEMBL3989977,,,,
Enasidenib,N,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB13874"">DB13874</a>",L01XX59,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989908"">CHEMBL3989908</a>",Refractory Acute Myelogenous Leukemia (AML); Relapsed Acute Myelogenous Leukemia (AML),IDH2; FLT3,17/09/2020,CHEMBL3989908,,,,
Encorafenib,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB11718"">DB11718</a>",L01EC03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301612"">CHEMBL3301612</a>",Metastatic Melanoma; Unresectable Melanoma,ARAF; RAF1; BRAF; PTEN; KRAS; MAP2K1,1/2/2022,CHEMBL3301612,,,,
Enfortumab Vedotin,Y,Y,N,,N,2021,N,"<a href=""https://go.drugbank.com/drugs/DB13007"">DB13007</a>",L01FX13,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301589"">CHEMBL3301589</a>","Locally Advanced Urothelial Cancer, Metastatic Urothelial Cancer",NECTIN4,1/2/2022,CHEMBL3301589,,,,
Entrectinib,Y,Y,N,,N,2019,N,"<a href=""https://go.drugbank.com/drugs/DB11986"">DB11986</a>",L01EX14,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1983268"">CHEMBL1983268</a>","Metastatic Solid Tumors; Non-Small Cell Lung Carcinoma (NSCLC); Tumors, Solid",NTRK3; NTRK2; ROS1; NTRK1; EML4; NPM1; CAMK1D; ETV6; GRK5; TBK1; ALK,1/2/2022,CHEMBL1983268,,,,
Enzalutamide,Y,Y,N,,N,2012,N,"<a href=""https://go.drugbank.com/drugs/DB08899"">DB08899</a>",L02BB04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1082407"">CHEMBL1082407</a>",Metastatic Castration Resistant Prostate Cancer,AR; PTEN,1/2/2022,CHEMBL1082407,,,,
Epirubicin,N,Y,Y,,N,1999,Y,"<a href=""https://go.drugbank.com/drugs/DB00445"">DB00445</a>",L01DB03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL417"">CHEMBL417</a>",Breast Cancer; Breast Cancer Stage II; Breast Cancer Stage III; Colorectal Cancers; Hormone Refractory Prostate Cancer; Non-Small Cell Lung Carcinoma (NSCLC); Ovarian Cancer; Papillary transitional cell carcinoma of bladder; Recurrent Superficial Bladder Cancer; Small Cell Lung Cancer (SCLC); Soft Tissue Sarcoma (STS); Stomach Tumor; Carcinoma in situ of urinary bladder,TOP2A; CHD1; GSTP1; PON1; IRS1; MDM4; PERP; GNL3; BIRC5; CYP1B1; BCL2; CBR3; TP53AIP1; CCNK; PPP2R5D; HMMR; SERPINE1; NOS3; FOXO1; RBX1; FOXP3,1/2/2022,CHEMBL417,,,,
Erdafitinib,N,Y,N,,N,2019,N,"<a href=""https://go.drugbank.com/drugs/DB12147"">DB12147</a>",L01EN01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545376"">CHEMBL3545376</a>","Locally Advanced, Susceptible FGFR3 or FGFR2 genetic alterations, Condition has progressed during or following at least one line of prior platinum- containing chemotherapy including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy urothelial carcinoma; Metastatic Susceptible FGFR3 or FGFR2 genetic alterations, Condition has progressed during or following at least one line of prior platinum- containing chemotherapy including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy Metastatic Urothelial Carcinoma",FGFR2; FGFR1; FGFR3; KRAS; EGFR,22/06/2022,CHEMBL3545376,,,,
Eribulin,Y,Y,N,,N,2010,N,"<a href=""https://go.drugbank.com/drugs/DB08871"">DB08871</a>",L01XX41,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1683590"">CHEMBL1683590</a>","Metastatic Liposarcoma; Refractory, metastatic Breast cancer; Unresectable Liposarcoma",ERBB2; TUB; ESR2; PGR; CDK2; ESR1,22/06/2022,CHEMBL1683590,,,,
Erlotinib,Y,Y,N,,Y,2004,Y,"<a href=""https://go.drugbank.com/drugs/DB00530"">DB00530</a>",L01EB02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL553"">CHEMBL553</a>",Locally Advanced Non-Small Cell Lung Cancer; Locally Advanced Pancreatic Cancer; Metastatic Non-Small Cell Lung Cancer; Non-Small Cell Lung Carcinoma (NSCLC); Pancreatic Cancer Metastatic,EGFR; ERBB4; CDH1; DDR2; KRAS; FGFR4; MAP3K1; NRG1; APC; CBL; ERRFI1,14/11/2022,CHEMBL553,,,,
Estramustine,N,Y,Y,,N,1981,N,"<a href=""https://go.drugbank.com/drugs/DB01196"">DB01196</a>",L01XX11,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1575"">CHEMBL1575</a>",Metastatic Hormone Refractory Prostate Cancer,BAX; KLK3; BCL2; HEXB,28/10/2021,CHEMBL1575,,,,
Etoposide,N,Y,Y,,Y,1983,Y,"<a href=""https://go.drugbank.com/drugs/DB00773"">DB00773</a>",L01CB01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL44657"">CHEMBL44657</a>","Acute Lymphoblastic Leukaemias (ALL); Acute Myeloid Leukemia (AML); Advanced Hodgkin&#39;s Lymphoma; Ewing&#39;s Sarcoma; Merkel cell cancer; Multiple Myeloma (MM); Neuroblastomas; Neuroendocrine Tumours; Non-Hodgkin&#39;s Lymphoma (NHL); Non-Small Cell Lung Carcinoma (NSCLC); Ovarian Cancer; Prostate Cancer; Retinoblastoma; Sarcoma, Osteogenic; Small Cell Lung Cancer (SCLC); Wilms&#39; tumor; Locally advanced Thymoma; Metastatic Thymic Cancer; Refractory Sarcoma; Refractory Testicular cancer",TOP2A; TOP2B; SLIT1; PAPOLA; EIF4E; TNFSF13B; MUC16; ITGAL; IGF2; GDF15; NCOA1; NCOA3; BTF3P11; ERCC2; DYNC2H1; PLA2G6; MYCN; GSTT1; ACTR2; UGT1A10; KLK3; AFP; E2F1; UGT1A1; BRCA2; PGP; PLA2G1B,1/2/2022,CHEMBL44657,,,,
Everolimus,Y,Y,N,,N,2009,Y,"<a href=""https://go.drugbank.com/drugs/DB01590"">DB01590</a>",L04AA18; L01EG02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1908360"">CHEMBL1908360</a>","Subependymal giant cell astrocytoma, tuberous sclerosis complex; Advanced Carcinoid tumor; Locally advanced gastrointestinal origin Progressive Neuroendocrine Tumors; Locally advanced lung origin Progressive Neuroendocrine Tumors; Metastatic gastrointestinal origin Progressive Neuroendocrine Tumors; Metastatic lung origin Progressive Neuroendocrine Tumors; Pancreatic origin Progressive Neuroendocrine Tumors; Refractory Advanced Renal Cell Carcinoma; Refractory Waldenstrom&#39;s Macroglobulinaemia; Refractory, advanced Breast cancer; Unresectable gastrointestinal origin Progressive Neuroendocrine Tumors; Unresectable lung origin Progressive Neuroendocrine Tumors",MTOR; FKBP1A; GNAQ; RPTOR; BRCA2; STK11; BRAF; RB1; NF2; HRAS; BAP1; KDM5C; PTEN; NOTCH1; NRAS; FLCN; VHL; PIK3CA; TSC2; TSC1; MPL; PBRM1; GNA11,14/11/2022,CHEMBL1908360,,,,
Exemestane,N,Y,Y,,N,1999,Y,"<a href=""https://go.drugbank.com/drugs/DB00990"">DB00990</a>",L02BG06,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200374"">CHEMBL1200374</a>","Early Breast Cancer; Refractory, advanced Breast cancer",CYP19A1; AKR1C3; PGR; AKR1C4; KMT2C; MAP4K4; TUBB1; CYP1B1; BGLAP,14/11/2022,CHEMBL1200374,,,,
Fedratinib,Y,Y,N,,N,2019,N,"<a href=""https://go.drugbank.com/drugs/DB12500"">DB12500</a>",L01EJ02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1287853"">CHEMBL1287853</a>",,JAK2; FLT3,22/06/2022,CHEMBL1287853,,,,
Fludarabine,N,Y,Y,,Y,1991,Y,"<a href=""https://go.drugbank.com/drugs/DB01073"">DB01073</a>",L01BB05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1568"">CHEMBL1568</a>",B-cell chronic lymphocytic leukemia/prolymphocytic leukemia/small lymphocytic lymphoma refractory; Refractory Non-Hodgkin&#39;s lymphoma,RRM1; POLA1; DCK; IKZF1; ATM; SULT2B1; CXCL12; SLC22A12; SLC29A1; ADA; MPO; SLCO1B1; CD40; BAX; XIAP; CYP2E1,22/06/2022,CHEMBL1568,,,,
Fluorouracil,N,Y,Y,,Y,1962,Y,"<a href=""https://go.drugbank.com/drugs/DB00544"">DB00544</a>",L01BC02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL185"">CHEMBL185</a>",Breast Cancer; Malignant Neoplasm of Colon; Malignant Neoplasm of Pancreas; Malignant Neoplasm of Stomach; Rectal Carcinoma; Superficial Basal Cell Carcinoma,TYMS; ABCC11; GNL3; GALNT14; SELE; KLC1; IL11; PERP; ENOSF1; SHMT1; HLA-G; TYMP; ALCAM; IL6R; ABCC5; TP53AIP1; CBLB; IGFBP3; SMAD4; PPP2R5D; SLC19A1; SLC22A16; PTPRC; XRCC1; XRCC3; DLG5; EXO1; DPYS; DPYD; ABCG1; CYP2A6; TSHB; RGS5; TPT1; RBX1; PARD3B; NT5C1A; MYB; ALDH3A1; WNT5B; REV3L; XRCC4; MUC2; ERCC1; CDKN1A; MTHFR; MIR27A; NOS3; CCNK; CDC25C; PON1; DKK1; LGR5; CBR1; FPGS; UMPS; DTYMK; TMEM167A; CHN2; MEGF11; FOXO1; CBR3; HMMR; NQO1,14/11/2022,CHEMBL185,,,,
Fluoxymesterone,N,Y,N,,N,1956,Y,"<a href=""https://go.drugbank.com/drugs/DB01185"">DB01185</a>",G03BA01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1445"">CHEMBL1445</a>","Inoperable, metastatic Breast cancer",AR; NR3C1; PRL,17/09/2020,CHEMBL1445,,,,
Flutamide,N,Y,Y,,N,1989,Y,"<a href=""https://go.drugbank.com/drugs/DB00499"">DB00499</a>",L02BB01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL806"">CHEMBL806</a>",C Prostatic Carcinoma; Stage B2 Prostatic Carcinoma; Stage D2 Prostatic carcinoma,BIRC5; TH; PEBP1; CDKN1A; IL2RA; AQP9; VIP; KLK3; MPO,1/2/2022,CHEMBL806,,,,
Fotemustine,Y,N,N,,N,,,"<a href=""https://go.drugbank.com/drugs/DB04106"">DB04106</a>",L01AD05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL549386"">CHEMBL549386</a>",Metastatic Melanoma,TXNRD1; MGMT,17/09/2020,CHEMBL549386,,,,
Fulvestrant,Y,Y,N,,N,2002,Y,"<a href=""https://go.drugbank.com/drugs/DB00947"">DB00947</a>",L02BA03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1358"">CHEMBL1358</a>","Advanced or Metastatic Breast Cancer; Refractory, advanced Breast cancer; Refractory, metastatic Breast cancer",ESR1; ESR2; FGFR2; TFPI; PGR; CDK6; PIK3CA; CCNE1; PTEN; EPHX2; ESRRA,14/11/2022,CHEMBL1358,,,,
Futibatinib,N,Y,N,,N,2022,,"<a href=""https://go.drugbank.com/drugs/DB15149"">DB15149</a>",L01EN04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/ CHEMBL3701238""> CHEMBL3701238</a>","Locally Advanced Intrahepatic Cholangiocarcinoma, Metastatic Intrahepatic Cholangiocarcinoma, Unresectable Intrahepatic Cholangiocarcinoma",,14/11/2022, CHEMBL3701238,,,,
Gefitinib,Y,Y,N,,Y,2003,Y,"<a href=""https://go.drugbank.com/drugs/DB00317"">DB00317</a>",L01EB01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL939"">CHEMBL939</a>",Metastatic Non-Small Cell Lung Cancer,EGFR; ERBB3; IKBKE; SIRT2; NFKBIB; MAP3K1; CRKL; SIK2; CEACAM5; PBK; TAB2; EMP1; SMO; IGF2; NR1H2; NFKBIA,22/06/2022,CHEMBL939,,,,
Gemcitabine,N,Y,Y,,Y,1996,Y,"<a href=""https://go.drugbank.com/drugs/DB00441"">DB00441</a>",L01BC05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL888"">CHEMBL888</a>","Advanced Ovarian Cancer; Bladder Transitional Cell Carcinoma Stage IV; Cervical Cancers; Cutaneous T-Cell Lymphoma (CTCL); Head and Neck Carcinoma; Hodgkins Disease (HD); Locally Advanced Pancreatic Adenocarcinoma; Mesothelioma; Metastatic Breast Cancer; Non-Small Cell Lung Cancer Stage IIIB; Non-small Cell Lung Cancer (NSCLC), Stage IV; Non-small Cell Lung Cancer Stage IIIA; Small Cell Lung Cancer (SCLC); Stage 4 Pancreatic adenocarcinoma",CMPK1; RRM2; RRM1; CBL; HLA-C; SLC28A3; ATAT1; SLC28A1; POLR1G; SLC29A2; FKBP5; SMAD4; SLC29A1; NT5C1A; SLC29A3; CDA; SERPINA5; PRRC2A; XRCC1; SH2D5; GPX5; NT5C3A; IGF2; ATRX; CDSN; ALG10; WEE1; XYLT2; DCTD; MSH5; PPCDC; NT5C; PPP1R13L; CDC5L; ETS2; PPP1R18; CIP2A; ACSS2; ERCC1; DOCK8; SLC28A2; TENT4A; DCK; MUCL3; KLC3; DAPK1; C6ORF15; POLR2A; PSORS1C1; FANCC; FHL2; NT5C2; HCP5,1/2/2022,CHEMBL888,,,,
Gemtuzumab Ozogamicin,Y,Y,N,,N,2000,N,"<a href=""https://go.drugbank.com/drugs/DB00056"">DB00056</a>",L01FX02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201506"">CHEMBL1201506</a>",Acute Myeloid Leukemia (AML); Refractory Acute Myelogenous Leukemia (AML); Relapsed Acute Myelogenous Leukemia (AML),ABCB1; CD33,1/2/2022,CHEMBL1201506,,,,
Gilteritinib,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB12141"">DB12141</a>",L01EX13,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301622"">CHEMBL3301622</a>",Relapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations,AXL; FLT3,22/06/2022,CHEMBL3301622,,,,
Glasdegib,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB11978"">DB11978</a>",L01XJ03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2043437"">CHEMBL2043437</a>",Acute Myeloid Leukemia (AML),SMO; MTOR,17/09/2020,CHEMBL2043437,,,,
Goserelin,N,Y,Y,,N,1989,N,"<a href=""https://go.drugbank.com/drugs/DB00014"">DB00014</a>",L02AE03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201247"">CHEMBL1201247</a>",Advanced Breast Cancer; Early Breast Cancer; Advanced carcinoma of the prostate; Stage M1 hormone dependent carcinoma of the prostate; Stage T2b carcinoma of the prostate; Stage T2c carcinoma of the prostate; Stage T3 carcinoma of the prostate; Stage T4 carcinoma of the prostate,LHCGR; ESR2; MYOD1; PGR; GNRH1; ESR1,22/06/2022,CHEMBL1201247,,,,
Histamine dihydrochloride,Y,Y,N,,N,1939,N,"<a href=""https://go.drugbank.com/drugs/DB05381"">DB05381</a>",L03AX14,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL90"">CHEMBL90</a>",,HRH4; HRH2; SLC29A4; LMNA,22/06/2022,CHEMBL90,,,,
Histrelin,N,Y,N,,N,1991,N,"<a href=""https://go.drugbank.com/drugs/DB06788"">DB06788</a>",L02AE05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201255"">CHEMBL1201255</a>",Advanced Prostate Cancer,GNRHR; GNRHR2,22/09/2020,CHEMBL1201255,,,,
Hydroxycarbamide,N,Y,N,,Y,1967,Y,"<a href=""https://go.drugbank.com/drugs/DB01005"">DB01005</a>",L01XX05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL467"">CHEMBL467</a>","Essential Thrombocythemia (ET); Head and Neck Carcinoma; Melanomas; Ovarian Cancer Metastatic; Polycythemia Vera (PV); Chronic, refractory Myeloid Leukemia; Inoperable Ovarian cancer",RRM2; RRM1; RRM2B; CP; DNTT; MAP3K5; DUSP1; EIF4E; PTH; ABL1; DNMT1; HRAS,14/11/2022,CHEMBL467,,,,
Ibritumomab Tiuxetan,Y,Y,N,,N,2002,N,"<a href=""https://go.drugbank.com/drugs/DB00078"">DB00078</a>",V10XX02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201606"">CHEMBL1201606</a>",Follicular Non-Hodgkin&#39;s Lymphoma; Follicular Non-Hodgkin&#39;s Lymphoma Refractory,MS4A1,17/09/2020,CHEMBL1201606,,,,
Ibrutinib,Y,Y,N,,N,2013,N,"<a href=""https://go.drugbank.com/drugs/DB09053"">DB09053</a>",L01EL01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1873475"">CHEMBL1873475</a>",Chronic Lymphocytic Leukaemia (CLL); Mantle Cell Lymphoma (MCL); Waldenstrom&#39;s Macroglobulinemia (WM),BTK; ERBB2; BMX; LYN; PLCG2; MYD88; ATM; MYC,22/06/2022,CHEMBL1873475,,,,
Idarubicin,N,Y,Y,,N,1990,Y,"<a href=""https://go.drugbank.com/drugs/DB01177"">DB01177</a>",L01DB06,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1117"">CHEMBL1117</a>",Acute Myeloid Leukemia (AML),TOP2A; NT5C3A; ETV6; RAC2; CYP2E1; SLC22A12; SULT2B1; NCF4; DNMT3A; DCK; CYBA,1/2/2022,CHEMBL1117,,,,
Idecabtagene Vicleucel,Y,Y,N,,N,2021,N,"<a href=""https://go.drugbank.com/drugs/DB16665"">DB16665</a>",L01XL07,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298199"">CHEMBL4298199</a>","Refractory Multiple Myeloma, Relapsed Multiple Myeloma",TNFRSF17,23/10/2022,CHEMBL4298199,,,,
Idelalisib,Y,Y,N,,N,2014,N,"<a href=""https://go.drugbank.com/drugs/DB09054"">DB09054</a>",L01EM01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2216870"">CHEMBL2216870</a>",Relapsed Chronic Lymphocytic Leukemia; Relapsed Small Lymphocytic Lymphoma; Relapsed follicular B-cell non-Hodgkin lymphoma,PIK3CA; PIK3CD; BRAF; PTEN,22/06/2022,CHEMBL2216870,,,,
Ifosfamide,N,Y,Y,,Y,1988,Y,"<a href=""https://go.drugbank.com/drugs/DB01181"">DB01181</a>",L01AA06,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1024"">CHEMBL1024</a>","Cancer, Bladder; Cervical Cancers; Ewing&#39;s Sarcoma; Head and Neck Carcinoma; Lymphoma, Hodgkins; Malignant Neoplasm of Pancreas; Non-Hodgkin&#39;s Lymphoma (NHL); Ovarian Cancer; Sarcoma, Osteogenic; Small Cell Lung Cancer (SCLC); Soft Tissue Sarcoma (STS); Testicular Germ Cell Cancer; Advanced thymic carcinoma",IL6; DNMT1; CYP2A6; GSTP1; HSPA4; NR1I2; MGMT; CYP2B6,1/2/2022,CHEMBL1024,,,,
Imatinib,Y,Y,N,,Y,2001,Y,"<a href=""https://go.drugbank.com/drugs/DB00619"">DB00619</a>",L01EA01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL941"">CHEMBL941</a>","Chordomas; Chronic Eosinophilic Leukemia (CEL); Chronic Myeloid Leukemia (CML); Desmoid Tumors; FIP1L1-PDGFRa fusion kinase status unknown Chronic eosinophilic leukemia; Metastatic Gastrointestinal Stromal Tumor; Metastatic Melanoma; Myelodysplastic Syndromes (MDS); Refractory Acute Lymphoblastic Leukemia; Metastatic Dermatofibrosarcoma protuberans; Newly diagnosed Acute Lymphoblastic Leukaemia; Newly diagnosed, chronic phase Chronic myeloid leukemia; Recurrent Dermatofibrosarcoma protuberans; Refractory, accelerated phase Chronic myeloid leukemia; Refractory, blast crisis Chronic myeloid leukemia; Refractory, chronic phase Chronic myeloid leukemia; Systemic mastocytosis with associated hematological neoplasm; Unresectable Gastrointestinal stromal tumor",ABL1; PDGFRB; KIT; PDGFRA; BCR; DDR1; NTRK1; CSF1R; SLC19A1; ETV6; ABCB4; PDGFB; CD40LG; ULK3; CHST1; CYP2F1; CTNNB1; SLC22A5; ABCG2; BCL2L11; SLC22A4; SLCO1A2; UGT2A1; GSTT1; XIAP; RCSD1; ABL2; FIP1L1; QUINONE REDUCTASE 2; IKZF1; SFN; SMAD4; SLC22A1,14/11/2022,CHEMBL941,,,,
Imiquimod,Y,Y,N,,N,1997,Y,"<a href=""https://go.drugbank.com/drugs/DB00724"">DB00724</a>",D06BB10,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1282"">CHEMBL1282</a>",Superficial Basal Cell Carcinoma,TLR7; IFNA1,17/09/2020,CHEMBL1282,,,,
Infigratinib,N,Y,N,,N,2021,N,"<a href=""https://go.drugbank.com/drugs/DB11886"">DB11886</a>",L01EN03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1852688"">CHEMBL1852688</a>","Unresectable, locally advanced Cholangiocarcinomas, Unresectable, metastatic Cholangiocarcinomas",PIK3C2G; FGFR2; FGFR1; FGFR4; FGFR3; PIK3C2B; PIK3C2A; PIK3R4; PIK3R6; PIK3C3,1/2/2022,CHEMBL1852688,,,,
Inotuzumab Ozogamicin,Y,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB05889"">DB05889</a>",L01FB01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108611"">CHEMBL2108611</a>",Refractory B-cell precursor acute lymphoblastic leukemia; Relapsed B cell precursor Acute lymphoblastic leukemia,CD22,1/2/2022,CHEMBL2108611,,,,
Interferon Alfa-2b,Y,Y,N,,N,1986,N,"<a href=""https://go.drugbank.com/drugs/DB00105"">DB00105</a>",L03AB05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201558"">CHEMBL1201558</a>","Hairy Cell Leukemia (HCL); Kaposi&#39;s sarcoma; Melanoma, Malignant",IFNAR1; IFNAR2,17/09/2020,CHEMBL1201558,,,,
Iobenguane,N,Y,N,,N,1994,N,"<a href=""https://go.drugbank.com/drugs/DB06704"">DB06704</a>",V09IX01; V09IX02; V10XA02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL818"">CHEMBL818</a>","Metastatic Pheochromocytoma; Metastatic Neuroblastoma; Primary Neuroblastomas; Primary Pheochromocytomas; Unresectable, locally advanced iobenguane-scan positive Paraganglioma; Unresectable, locally advanced iobenguane-scan positive Pheochromocytomas; Unresectable, metastatic iobenguane-scan positive Paraganglioma; Unresectable, metastatic iobenguane-scan positive Pheochromocytomas",TH; SLC6A2,17/09/2020,CHEMBL818,,,,
Ipilimumab,Y,Y,N,,N,2011,N,"<a href=""https://go.drugbank.com/drugs/DB06186"">DB06186</a>",L01FX04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1789844"">CHEMBL1789844</a>",Advanced Renal Cell Carcinoma; Cutaneous Melanoma; Hepatocellular Carcinoma; Metastatic Melanoma; Unresectable Melanoma; Metastatic MSI-H/dMMR colorectal cancer,CTLA4; PBRM1; MDM2; HLA-A; NRAS,1/2/2022,CHEMBL1789844,,,,
Irinotecan,N,Y,Y,,Y,1996,Y,"<a href=""https://go.drugbank.com/drugs/DB00762"">DB00762</a>",L01CE02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL481"">CHEMBL481</a>","Esophageal Cancers; Ewing&#39;s Sarcoma; Glioblastomas; Malignant Neoplasm of Pancreas; Malignant Neoplasm of Stomach; Metastatic Colorectal Carcinoma; Non-Small Cell Lung Carcinoma (NSCLC); Ovarian Cancer; Rhabdomyosarcomas; Small Cell Lung Cancer (SCLC); Recurrent, IV-B Cervical cancer; Recurrent, metastatic Colorectal carcinoma; Refractory, metastatic Pancreatic adenocarcinoma",TOP1; TOP1MT; ISG15; ABCC5; UGT1A9; XRCC3; KRAS; C8ORF34; CES2; BRAF; TGFBR2; ABCG1; RAD50; RUNX3; BCHE; CES1; ATRX; AREG; E2F1; TYMS; SEMA3C; KLC1; SHMT1; UGT1A; SLC19A1; UBE2I; SMAD4; KCNQ5; DPYD; DCBLD1; RGS5; DKK1,14/11/2022,CHEMBL481,,,,
Irinotecan Liposome,Y,Y,N,,N,1996,Y,"<a href=""https://go.drugbank.com/drugs/DB00762"">DB00762</a>",L01XX19,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL481"">CHEMBL481</a>","Esophageal Cancers; Ewing&#39;s Sarcoma; Glioblastomas; Malignant Neoplasm of Pancreas; Malignant Neoplasm of Stomach; Metastatic Colorectal Carcinoma; Non-Small Cell Lung Carcinoma (NSCLC); Ovarian Cancer; Rhabdomyosarcomas; Small Cell Lung Cancer (SCLC); Recurrent, IV-B Cervical cancer; Recurrent, metastatic Colorectal carcinoma; Refractory, metastatic Pancreatic adenocarcinoma",TOP1; TOP1MT; ISG15; ABCC5; UGT1A9; XRCC3; KRAS; C8ORF34; CES2; BRAF; TGFBR2; ABCG1; RAD50; RUNX3; BCHE; CES1; ATRX; AREG; E2F1; TYMS; SEMA3C; KLC1; SHMT1; UGT1A; SLC19A1; UBE2I; SMAD4; KCNQ5; DPYD; DCBLD1; RGS5; DKK1,14/11/2022,CHEMBL481,,,,
Isatuximab,Y,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB14811"">DB14811</a>",L01FC02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545131"">CHEMBL3545131</a>",Multiple Myeloma (MM),CD38,1/2/2022,CHEMBL3545131,,,,
Ivosidenib,N,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB14568"">DB14568</a>",L01XX62,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989958"">CHEMBL3989958</a>","Refractory, relapsed Acute Myeloid Leukemia",IDH1,17/09/2020,CHEMBL3989958,,,,
Ixabepilone,N,Y,N,,N,2007,N,"<a href=""https://go.drugbank.com/drugs/DB04845"">DB04845</a>",L01DC04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201752"">CHEMBL1201752</a>",Locally Advanced Breast Cancer (LABC); Metastatic Breast Cancer,TUBB1; TUBB2A; TUBB3; PGR; TUB,22/06/2022,CHEMBL1201752,,,,
Ixazomib,Y,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB09570"">DB09570</a>",L01XG03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2141296"">CHEMBL2141296</a>",Multiple Myeloma (MM),PSMC5; NPM1,22/06/2022,CHEMBL2141296,,,,
Lanreotide,N,Y,Y,,N,2007,N,"<a href=""https://go.drugbank.com/drugs/DB06791"">DB06791</a>",H01CB03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201185"">CHEMBL1201185</a>","Unresectable, locally advanced enteropancreatic neuroendocrine tumors; Unresectable, locally advanced gastroenteropancreatic neuroendocrine tumors; Unresectable, metastatic enteropancreatic neuroendocrine tumors; Unresectable, metastatic gastroenteropancreatic neuroendocrine tumors",SSTR5; SSTR1; EDN1,22/06/2022,CHEMBL1201185,,,,
Lapatinib,Y,Y,N,,N,2007,Y,"<a href=""https://go.drugbank.com/drugs/DB01259"">DB01259</a>",L01EH01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL554"">CHEMBL554</a>","Metastatic Breast Cancer; Refractory, advanced Breast cancer; Refractory, metastatic Breast cancer",EGFR; ERBB2; ERBB4; ABCB11; CCND1; CDH1; EEF2K; HLA-DRB1; NRG1; CDKN1B; ERBB3; HLA-DQA1; PIK3CA; BIRC5,1/2/2022,CHEMBL554,,,,
Larotrectinib,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB14723"">DB14723</a>",L01EX12,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3889654"">CHEMBL3889654</a>",NTRK1 Fusion Positive; NTRK2 Fusion Positive; NTRK3 Fusion Positive,NTRK3; NTRK2; NTRK1; ETV6,17/09/2020,CHEMBL3889654,,,,
Lenalidomide,Y,Y,N,,Y,2005,Y,"<a href=""https://go.drugbank.com/drugs/DB00480"">DB00480</a>",L04AX04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL848"">CHEMBL848</a>",Chronic Lymphocytic Leukemia (CLL) - Refractory; Follicular Lymphoma (FL); Mantle Cell Lymphoma (MCL); Marginal Zone Lymphoma (MZL); Multiple Myeloma (MM); Myelodysplastic Syndrome; Refractory Diffuse Large B Cell Lymphoma,CUL4A; TNFSF11; CRBN; DDB1; RBX1; CTNNB1; TNF; IKZF1; FGF2; VEGFB; VEGFC; VEGFA,14/11/2022,CHEMBL848,,,,
Lenvatinib,Y,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB09078"">DB09078</a>",L01EX08,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1289601"">CHEMBL1289601</a>",Advanced Renal Cell Carcinoma; Locally recurrent radioactive iodine-refractory Thyroid cancer; Metastatic radioactive iodine-refractory Thyroid cancer; Progressive radioactive iodine-refractory Thyroid cancer,FLT4; FGFR2; RET; FLT1; KIT; KDR; FGFR1; PDGFRA; NRAS; BRAF,1/2/2022,CHEMBL1289601,,,,
Letrozole,N,Y,Y,,N,1997,Y,"<a href=""https://go.drugbank.com/drugs/DB01006"">DB01006</a>",L02BG04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1444"">CHEMBL1444</a>",Advanced Breast Cancer; Early Breast Cancer; Ovarian Epithelial Cancer; Advanced HR + HER2 - breast cancer; Metastatic HR + HER2 - breast cancer,CYP19A1; ESR2; MMP2; CDKN2A; PGR; CYP2A6; ESR1; CYP1B1; TNFRSF11B; KMT2C; TNFSF11,1/2/2022,CHEMBL1444,,,,
Leuprolide,N,Y,N,,N,1985,Y,"<a href=""https://go.drugbank.com/drugs/DB00007"">DB00007</a>",L02AE51; L02AE02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201199"">CHEMBL1201199</a>",Advanced Prostate Cancer,GNRHR; GNRH1,17/09/2020,CHEMBL1201199,,,,
Lisocabtagene Maraleucel,Y,Y,N,,N,2021,N,"<a href=""https://go.drugbank.com/drugs/DB16582"">DB16582</a>",,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297236"">CHEMBL4297236</a>","Grade 3b Follicular Lymphoma; High-grade B-cell Lymphoma (HGBCL); Primary mediastinal large B-cell lymphomas; Refractory Diffuse Large B Cell Lymphoma; Refractory Large B-cell Lymphoma; Relapsed Large B-cell Lymphoma; Relapsed, Diffuse Large B-cell Lymphoma",CD19,31/01/2022,CHEMBL4297236,,,,
Lomustine,N,Y,Y,,N,1976,N,"<a href=""https://go.drugbank.com/drugs/DB01206"">DB01206</a>",L01AD02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL514"">CHEMBL514</a>",Primary Brain Tumors; Refractory Hodgkin Lymphoma; Tumors Metastatic to Brain,MGMT; ADK; ATRX,17/09/2020,CHEMBL514,,,,
Loncastuximab Tesirine,Y,Y,N,,N,2021,N,"<a href=""https://go.drugbank.com/drugs/DB16222"">DB16222</a>",L01FX22,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297778"">CHEMBL4297778</a>","Refractory Large B-cell Lymphoma, Relapsed Large B-cell Lymphoma",,23/10/2022,CHEMBL4297778,,,,
Lorlatinib,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB12130"">DB12130</a>",L01ED05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3286830"">CHEMBL3286830</a>","Progressive, metastatic Anaplastic lymphoma kinase-positive Metastatic Non-Small Cell Lung Cancer",ROS1; ALK; EML4; NPM1; RB1,22/06/2022,CHEMBL3286830,,,,
Lu 177-Dotatate,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB13985"">DB13985</a>",,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989924"">CHEMBL3989924</a>",Gastroenteropancreatic Neuroendocrine Tumors,,17/09/2020,CHEMBL3989924,,,,
Lurbinectedin,N,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB12674"">DB12674</a>",L01XX69,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297516"">CHEMBL4297516</a>",Metastatic Small Cell Lung Cancer,,17/09/2020,CHEMBL4297516,,,,
Margetuximab,N,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB14967"">DB14967</a>",L01FD06,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2364649"">CHEMBL2364649</a>",HER2-positive Metastatic Breast Cancer,ERBB2; ERBB3,23/10/2022,CHEMBL2364649,,,,
Medroxyprogesterone,N,Y,Y,,N,1959,Y,"<a href=""https://go.drugbank.com/drugs/DB00603"">DB00603</a>",G03DA02; G03AC06; L02AB02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL717"">CHEMBL717</a>",Metastatic Renal Cell Carcinoma; Metastatic Endometrial carcinoma,PGR; MMP1; BAX; CYP1B1; ERG,14/11/2022,CHEMBL717,,,,
Megestrol,N,Y,Y,,N,1971,Y,"<a href=""https://go.drugbank.com/drugs/DB00351"">DB00351</a>",G03DB02; G03AC05; L02AB01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201139"">CHEMBL1201139</a>",Advanced Breast Cancer; Advanced Endometrial Cancer,PGR; NPSR1,14/11/2022,CHEMBL1201139,,,,
Melphalan,N,Y,Y,,Y,1964,Y,"<a href=""https://go.drugbank.com/drugs/DB01042"">DB01042</a>",L01AA03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL852"">CHEMBL852</a>",Multiple Myeloma (MM); Ovarian Epithelial Cancer; Severe Hodgkin Lymphoma,MGMT; PLAT; SLC7A5; ABCC1; CDKN1A; GSTP1; OPLAH; ABL1; FANCC; IFNG; CTLA4,14/11/2022,CHEMBL852,,,,
Melphalan Flufenamide,Y,Y,N,,N,2021,N,"<a href=""https://go.drugbank.com/drugs/DB16627"">DB16627</a>",L01AA10,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4303060"">CHEMBL4303060</a>",Relapsed Or Refractory Multiple Myeloma,,23/10/2022,CHEMBL4303060,,,,
Mercaptopurine,Y,Y,N,,Y,1953,Y,"<a href=""https://go.drugbank.com/drugs/DB01033"">DB01033</a>",L01BB02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1425"">CHEMBL1425</a>; <a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200751"">CHEMBL1200751</a>","Acute Lymphoblastic Leukaemias (ALL); Acute Promyelocytic Leukemia (APL); Lymphoma, Lymphoblastic",IMPDH1; HPRT1; PPAT; ITPA; NOTCH1; IL2RA; GATA3; HLA-DRB1; PACSIN2; GNMT; RB1; HLA-DQA1; NUDT15; TYMSOS; PRPS1; FTO; DROSHA; FOLH1; ABCC4; NT5C2; TPMT; SLC29A2; VCAM1; MTHFR,1/2/2022,CHEMBL1425,,,,CHEMBL1200751</a
Methotrexate,Y,Y,N,,Y,1953,Y,"<a href=""https://go.drugbank.com/drugs/DB00563"">DB00563</a>",L04AX03; L01BA01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL34259"">CHEMBL34259</a>","Acute Lymphocytic Leukemia (ALL); Acute Promyelocytic Leukemia (APL); Breast Cancer; Cancer, Bladder; Central Nervous System Lymphoma; Choriocarcinoma; Head and Neck Carcinoma; Meningeal leukemia; Sarcoma, Osteogenic; Small Cell Lung Cancer (SCLC); Soft Tissue Sarcoma (STS); Squamous Cell Carcinoma of Lung; Advanced Alibert-Bazin syndrome; Advanced non-Hodgkin lymphoma; Nonleukemic meningeal cancer",DHFR; ATIC; HLA-E; UGT1A10; FOLR1; UGT1A7; IL1RN; ABCC2; SULT2A1; HGF; CCND1; MTRR; ATP5F1E; FOXP3; NALCN; BMP7; S100A8; TAT; SLC46A1; ABCC4; SLC22A11; IKZF1; SPECC1L; TPM3; PYGL; UGT1A8; HLA-G; FPGS; SOD2; DROSHA; PACSIN2; UGT1A5; KIR2DS4; SLC16A7; ITPA; SLCO1B1; CDKN1B; SLC22A8; ADORA2A-AS1; SLC22A9; SLCO1A2; SHMT1; AFP; HLA-C; ADA; ENOSF1; LINC00251; ARID5B; S100A12; GGH; KLRD1; TLR4; KCNA1; TNFAIP3; HSPB2; PTPRM; FOLH1; SLAMF1; AMPD1; DOK5; ICAM3; NOS3,14/11/2022,CHEMBL34259,,,,
Midostaurin,Y,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB06595"">DB06595</a>",L01EX10,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL608533"">CHEMBL608533</a>",Acute Myeloid Leukemia (AML); Malignant mast cell neoplasm; Systemic mastocytosis with associated hematological neoplasm,KIT; PRKCA; PRKCZ; PRKCE; PRKCI; PRKCB; PDGFRA; PRKCQ; PRKCH; PRKD1; FLT3; PRKCG; HSPA4; ETV6; NPM1; STK32B; PIK3CB,22/06/2022,CHEMBL608533,,,,
Mifamurtide,Y,N,N,,N,2009,N,"<a href=""https://go.drugbank.com/drugs/DB13615"">DB13615</a>",L03AX15,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2111100"">CHEMBL2111100</a>; <a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107354"">CHEMBL2107354</a>","High-grade, nonmetastatic Osteosarcoma; Resectable, nonmetastatic Osteosarcoma",NOD2,17/09/2020,CHEMBL2111100,,,,CHEMBL2107354</a
Mitomycin,N,Y,Y,,N,1981,Y,"<a href=""https://go.drugbank.com/drugs/DB00305"">DB00305</a>",L01DC03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL105"">CHEMBL105</a>","Adenocarcinoma of the Pancreas; Adenocarcinoma of the Stomach; Breast Cancer; Cancer, Anal; Cancer, Bladder; Cervical Cancers; Head and Neck Carcinoma; Mesothelioma; Non-Small Cell Lung Carcinoma (NSCLC); Low-grade Upper Tract Urothelial Cancer (LG-UTUC)",BGLAP; PALB2; FANCC; VWF,14/11/2022,CHEMBL105,,,,
Mitoxantrone,N,Y,Y,,N,1987,Y,"<a href=""https://go.drugbank.com/drugs/DB01204"">DB01204</a>",L01DB07,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL58"">CHEMBL58</a>","Acute Lymphocytic Leukemia (ALL); Acute Myeloid Leukemia (AML); Acute Promyelocytic Leukemia (APL); Lymphoma, Hodgkins; Metastatic Breast Cancer; Non-Hodgkin&#39;s Lymphoma (NHL); Relapsed Leukemia; Relapsed Lymphomas; Hormone refractory, advanced Prostate cancer; Relapsed Hepatocellular carcinoma",TOP2A; UGT1A5; MBNL1; C10ORF67; GALNT14; PIM1; RPSA; DNMT1,22/06/2022,CHEMBL58,,,,
Mobocertinib,N,Y,N,,N,2021,N,"<a href=""https://go.drugbank.com/drugs/DB16390"">DB16390</a>",L01EB10,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4650319"">CHEMBL4650319</a>","Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer",,23/10/2022,CHEMBL4650319,,,,
Mogamulizumab,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB12498"">DB12498</a>",L01FX09,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743041"">CHEMBL1743041</a>",Refractory Mycosis Fungoides/Sezary Syndrome; Relapsed Mycosis Fungoides/Sezary Syndrome,CCR4,1/2/2022,CHEMBL1743041,,,,
Mosunetuzumab,Y,N,N,,N,2022,N,"<a href=""https://go.drugbank.com/drugs/DB15434"">DB15434</a>",,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297788"">CHEMBL4297788</a>","Relapsed follicular lymphoma, Refractory follicular lymphoma",MS4A1,22/06/2022,CHEMBL4297788,,,,
Moxetumomab Pasudotox,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB12688"">DB12688</a>",L01FB02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743043"">CHEMBL1743043</a>",Relapsed/Refractory Hairy Cell Leukemia,CD22,1/2/2022,CHEMBL1743043,,,,
Nab-Paclitaxel,Y,Y,N,,N,2005,Y,"<a href=""https://go.drugbank.com/drugs/Not found in DrugBank"">Not found in DrugBank</a>",L01CD01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL428647"">CHEMBL428647</a>",Advanced Cervical Cancer; Advanced Head and Neck Cancer; Advanced Ovarian Cancer; Advanced Soft Tissue Sarcoma; Esophageal Cancers; Fallopian Tube Cancer; Kaposi&#39;s sarcoma; Locally Advanced Non-Small Cell Lung Cancer; Malignant Neoplasm of Stomach; Malignant Peritoneal Neoplasm; Metastatic Bladder Cancer; Metastatic Breast Cancer; Metastatic Melanoma; Metastatic Non-Small Cell Lung Cancer; Non-Small Cell Lung Carcinoma (NSCLC); Ovarian Cancer; Pancreatic Adenocarcinoma Metastatic; Advanced Bladder cancer; Advanced Thymoma; Metastatic Penile cancer; Refractory Small cell lung cancer; Refractory Testicular germ cell cancer,TUBB; TUBB8; TUBA4A; TUBA3E; TUBB2A; TUBA1A; TUBB1; TUBB3; TUBA3D; TUBB2B; TUBA1C; TUBA1B; BCL2; TUBB4B; TUBB6; ACSS2; STMN1; MAP3K1; FNTB; ERCC2; FGD4; PDCD4; DSCAM; EPHA5; EIF4EBP1; MYB; SLC29A1; GSTT1; TUBB4A; PGP; SOD2; SLCO1B3; TUBA3C; LIF; TLE3; SMAD4; SPATA5; NFE2; MAD1L1; EDNRB; SOX10; TRIM5; ABCC10; FOS; ERCC1,22/06/2022,CHEMBL428647,,,,
Naxitamab,N,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB15965"">DB15965</a>",L01FX21,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297984"">CHEMBL4297984</a>","High risk, refractory Neuroblastomas of the bone or bone marrow; High risk, relapsed Neuroblastomas of the bone or bone marrow",,23/10/2022,CHEMBL4297984,,,,
Necitumumab,Y,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB09559"">DB09559</a>",L01FE03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743047"">CHEMBL1743047</a>",Metastatic Non-Small Cell Lung Cancer,EGFR; KRAS,1/2/2022,CHEMBL1743047,,,,
Nelarabine,Y,Y,N,,N,2005,Y,"<a href=""https://go.drugbank.com/drugs/DB01280"">DB01280</a>",L01BB07,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201112"">CHEMBL1201112</a>",Lymphoblastic lymphoma (Precursor T-lymphoblastic lymphoma/leukemia) refractory; Refractory Acute Lymphoblastic Leukemia,POLA1,14/11/2022,CHEMBL1201112,,,,
Neratinib,Y,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB11828"">DB11828</a>",L01EH02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL180022"">CHEMBL180022</a>",Breast Cancer,EGFR; ERBB2; PIK3CA; BRAF; HERC2; PGR; KRAS,1/2/2022,CHEMBL180022,,,,
Nilotinib,Y,Y,N,,Y,2007,N,"<a href=""https://go.drugbank.com/drugs/DB04868"">DB04868</a>",L01EA03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL255863"">CHEMBL255863</a>","Chronic Phase Chronic Myeloid Leukemia; Refractory Gastrointestinal stromal tumor; Refractory, accelerated phase Chronic myeloid leukemia",ABL1; KIT; PDGFRA; PDGFRB; DDR2; LYN; BCR; UGT1A1; ABCG2; FLT3,22/06/2022,CHEMBL255863,,,,
Nilutamide,N,Y,N,,N,1996,Y,"<a href=""https://go.drugbank.com/drugs/DB00665"">DB00665</a>",L02BB02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1274"">CHEMBL1274</a>",Metastatic Hormone Refractory Prostate Cancer,AR; KLK3,1/2/2022,CHEMBL1274,,,,
Nintedanib,Y,Y,N,,N,2014,N,"<a href=""https://go.drugbank.com/drugs/DB09079"">DB09079</a>",L01EX09,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL502835"">CHEMBL502835</a>",Locally advanced Non-Small Cell Lung Cancer (NSCLC) caused by Adenocarcinoma; Locally recurrent Non-Small Cell Lung Cancer (NSCLC) caused by Adenocarcinoma; Metastatic Non-Small Cell Lung Cancer (NSCLC) caused by Adenocarcinoma,FRK; LYN; SRC; FLT4; FGFR2; FGR; PDGFRA; FLT1; PDGFRB; FGFR3; HCK; FGFR1; KDR; LCK; FLT3; FGFR4; CFLAR,22/06/2022,CHEMBL502835,,,,
Niraparib,Y,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB11793"">DB11793</a>",L01XK02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1094636"">CHEMBL1094636</a>",Fallopian Tube Cancer; Ovarian Epithelial Cancer; Primary Peritoneal Cancer,PARP1; PARP2; BRCA1; SLFN11; BRCA2; ATR; ATM,1/2/2022,CHEMBL1094636,,,,
Nivolumab,Y,Y,N,,Y,2015,N,"<a href=""https://go.drugbank.com/drugs/DB09035"">DB09035</a>",L01FF01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108738"">CHEMBL2108738</a>",Advanced Renal Cell Cancer; Classical Hodgkin&#39;s Lymphoma; Hepatocellular Carcinoma; Low Risk Advanced Renal Cell Cancer; Melanomas; Metastatic Colorectal Cancer (MCRC); Metastatic Melanoma; Metastatic Non-Small Cell Lung Cancer; Metastatic Small Cell Lung Cancer; Metastatic Squamous Cell Carcinoma of the Head and Neck; Metastatic Urothelial Carcinoma (UC); Recurrent Head and Neck Squamous Cell Carcinoma; Unresectable Melanoma; Intermediate risk Advanced Renal Cell Cancer; Locally advanced Urothelial Carcinoma,PDCD1; STK11; ARID1A; MDM2; PTEN; HLA-DRA; MDM4; PMS2; CDK12; PBRM1; EGFR; ALK; CD274,1/2/2022,CHEMBL2108738,,,,
Obinutuzumab,Y,Y,N,,N,2013,N,"<a href=""https://go.drugbank.com/drugs/DB08935"">DB08935</a>",L01FA03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743048"">CHEMBL1743048</a>",Refractory Follicular Lymphoma; Previously untreated Chronic lymphocytic leukemia,MS4A1,1/2/2022,CHEMBL1743048,,,,
Ofatumumab,Y,Y,N,,N,2009,N,"<a href=""https://go.drugbank.com/drugs/DB06650"">DB06650</a>",L04AA52; L01FA02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201836"">CHEMBL1201836</a>",Chronic Lymphocytic Leukaemia (CLL); Chronic Lymphocytic Leukemia (CLL) - Refractory; Progressive Chronic Lymphocytic Leukaemia (CLL); Recurrent Chronic Lymphocytic Leukaemia (CLL),MS4A1,1/2/2022,CHEMBL1201836,,,,
Olaparib,Y,Y,N,,N,2014,N,"<a href=""https://go.drugbank.com/drugs/DB09074"">DB09074</a>",L01XK01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL521686"">CHEMBL521686</a>",Fallopian Tube Cancer; Malignant Peritoneal Neoplasm; Metastatic Breast Cancer; Ovarian Epithelial Cancer; Primary Peritoneal Cancer; Advanced deleterious germline or somatic BRCA-mutated advanced epithelial ovarian cancer; Advanced deleterious germline or somatic BRCA-mutated fallopian tube cancer; Advanced deleterious germline or somatic BRCA-mutated peritoneal cancer; Refractory Advanced Ovarian Cancer,PARP2; PARP3; PARP1; IDH2; ATR; BARD1; CBLC; BRCA2; BAP1; CHEK1; VHL; STAG2; BRCA1; CDK12; PALB2; ATM; MYC,1/2/2022,CHEMBL521686,,,,
Olaratumab,Y,Y,N,,N,2016,N,"<a href=""https://go.drugbank.com/drugs/DB06043"">DB06043</a>",L01FX10,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743049"">CHEMBL1743049</a>",Soft Tissue Sarcoma (STS),PDGFRA,1/2/2022,CHEMBL1743049,,,,
Omacetaxine Mepesuccinate,N,Y,N,,N,2009,N,"<a href=""https://go.drugbank.com/drugs/DB04865"">DB04865</a>",L01XX40,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL46286"">CHEMBL46286</a>","Refractory, accelerated phase Chronic myeloid leukemia; Refractory, chronic phase Chronic myeloid leukemia",TERT; ABL1; BCR; BIRC5,17/09/2020,CHEMBL46286,,,,
Osimertinib,Y,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB09330"">DB09330</a>",L01EB04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3353410"">CHEMBL3353410</a>",Metastatic Non-Small Cell Lung Cancer,EGFR; ERBB2; MET; KRAS; NRAS,17/09/2020,CHEMBL3353410,,,,
Oxaliplatin,N,Y,Y,,Y,2002,Y,"<a href=""https://go.drugbank.com/drugs/DB00526"">DB00526</a>",L01XA03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL414804"">CHEMBL414804</a>",Advanced Colorectal Cancer; Advanced Ovarian Cancer; Advanced Pancreatic Cancer; Chronic Lymphocytic Leukemia (CLL) - Refractory; Colon Cancer Stage III; Esophageal Cancers; Malignant Neoplasm of Stomach; Advanced biliary adenocarcinoma; Refractory Neuroendocrine Tumour; Refractory Non-Hodgkin&#39;s lymphoma; Refractory Testicular cancer,DPYD; GSTP1; BAX; NOS3; VEGFA; NQO1; ATP7B; ZEB1; CSMD1; DKK1; SELE; ABCC5; BCL2; ATP7A; KLC3; MT1A; CXCL10; MTHFR; MGAT4A; FOXC2; ERCC1; PON1; PARD3B; GNA13; ERCC2,1/2/2022,CHEMBL414804,,,,
Paclitaxel,Y,Y,N,,Y,1992,Y,"<a href=""https://go.drugbank.com/drugs/DB01229"">DB01229</a>",L01CD01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL428647"">CHEMBL428647</a>",Advanced Cervical Cancer; Advanced Head and Neck Cancer; Advanced Ovarian Cancer; Advanced Soft Tissue Sarcoma; Esophageal Cancers; Fallopian Tube Cancer; Kaposi&#39;s sarcoma; Locally Advanced Non-Small Cell Lung Cancer; Malignant Neoplasm of Stomach; Malignant Peritoneal Neoplasm; Metastatic Bladder Cancer; Metastatic Breast Cancer; Metastatic Melanoma; Metastatic Non-Small Cell Lung Cancer; Non-Small Cell Lung Carcinoma (NSCLC); Ovarian Cancer; Pancreatic Adenocarcinoma Metastatic; Advanced Bladder cancer; Advanced Thymoma; Metastatic Penile cancer; Refractory Small cell lung cancer; Refractory Testicular germ cell cancer,TUBB; TUBB8; TUBA4A; TUBA3E; TUBB2A; TUBA1A; TUBB1; TUBB3; TUBA3D; TUBB2B; TUBA1C; TUBA1B; BCL2; TUBB4B; TUBB6; ACSS2; STMN1; MAP3K1; FNTB; ERCC2; FGD4; PDCD4; DSCAM; EPHA5; EIF4EBP1; MYB; SLC29A1; GSTT1; TUBB4A; PGP; SOD2; SLCO1B3; TUBA3C; LIF; TLE3; SMAD4; SPATA5; NFE2; MAD1L1; EDNRB; SOX10; TRIM5; ABCC10; FOS; ERCC1,14/11/2022,CHEMBL428647,,,,
Padeliporfin,Y,N,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB15575"">DB15575</a>",L01XD07,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298112"">CHEMBL4298112</a>",Low-Risk Prostate Cancer of the one lobe only,,17/09/2020,CHEMBL4298112,,,,
Palbociclib,Y,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB09073"">DB09073</a>",L01EF01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL189963"">CHEMBL189963</a>","Advanced Breast Cancer; Metastatic Breast Cancer; Refractory, advanced Breast cancer; Refractory, metastatic Breast cancer",CDK6; CDK4; CCND1; DYRK1B; CDKN2A; SMARCA4; SMARCB1; CDKN2B; RB1; PRKX; CCNE1; CCND3,1/2/2022,CHEMBL189963,,,,
Panitumumab,Y,Y,N,,N,2006,N,"<a href=""https://go.drugbank.com/drugs/DB01269"">DB01269</a>",L01FE02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201827"">CHEMBL1201827</a>",Metastatic Colorectal Cancer (MCRC),EGFR; HRAS; NRG3; NRG2; HBEGF; TGFA; BTC; BRAF; EGF; KRAS; AREG; NRAS; MAP2K1; EREG; NRG1; CDKN2A,1/2/2022,CHEMBL1201827,,,,
Panobinostat,Y,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB06603"">DB06603</a>",L01XH03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL483254"">CHEMBL483254</a>",Refractory Multiple Myeloma,HDAC8; HDAC7; HDAC1; HDAC6; HDAC2; HDAC5; HDAC9; HDAC4; HDAC3; HDAC10; HDAC11; MYCN; SMARCB1; KRAS; KMT2A; BAP1,1/2/2022,CHEMBL483254,,,,
Pazopanib,Y,Y,N,,N,2009,Y,"<a href=""https://go.drugbank.com/drugs/DB06589"">DB06589</a>",L01EX03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL477772"">CHEMBL477772</a>",Advanced Renal Cell Carcinoma; Advanced Soft Tissue Sarcoma; Advanced Thyroid cancer,PDGFRB; FLT4; PDGFRA; FLT1; KIT; KDR; FGFR3; NEK2; CYP2C8; FGFR2; HLA-B; UGT1A1,14/11/2022,CHEMBL477772,,,,
Pegaspargase,Y,Y,N,,Y,1994,N,"<a href=""https://go.drugbank.com/drugs/DB00059"">DB00059</a>",L01XX24,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108546"">CHEMBL2108546</a>",Acute Lymphoblastic Leukaemias (ALL),LINC00251; GATA3; BMP7; DOK5,17/09/2020,CHEMBL2108546,,,,
Peginterferon Alfa-2b,Y,Y,N,,N,2001,N,"<a href=""https://go.drugbank.com/drugs/DB00022"">DB00022</a>",L03AB10,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201561"">CHEMBL1201561</a>",Melanomas,IFNAR2; IFNAR1,17/09/2020,CHEMBL1201561,,,,
Pembrolizumab,Y,Y,N,,Y,2014,N,"<a href=""https://go.drugbank.com/drugs/DB09037"">DB09037</a>",L01FF02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3137343"">CHEMBL3137343</a>","Advanced Renal Cell Carcinoma; Cervical Cancers; Colorectal Cancers; Metastatic Melanoma; Metastatic Solid Tumors; Unresectable Melanoma; Urothelial carcinoma ureter metastatic; Locally advanced Urothelial Carcinoma; Locally advanced gastroesphageal juntion adenocarcinoma; Metastatic gastroesphageal juntion adenocarcinoma; Metastatic nonsquamous non-small cell lung cancer; Recurrent, metastatic Head and Neck Squamous Cell Carcinoma; Refractory, metastatic Non small cell lung cancer; Refractory, relapsed Hodgkin Lymphoma; Refractory, relapsed Mediastinal Large B-cell Lymphoma; Unresectable Solid Tumors",PDCD1; PDCD1LG2; B2M; MDM2; CDK12; PBRM1; STK11; ARID1A; CD274; ALK; MDM4; POLE; HLA-DRA; EGFR; JAK1; JAK2; NRAS; BRAF; PTEN,1/2/2022,CHEMBL3137343,,,,
Pemetrexed,Y,Y,N,,N,2004,Y,"<a href=""https://go.drugbank.com/drugs/DB00642"">DB00642</a>",L01BA04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL225072"">CHEMBL225072</a>","Mesothelioma; Ovarian Cancer; Pleural Mesotheliomas; Urothelial carcinoma ureter metastatic; Locally advanced nonsquamous non-small cell lung cancer; Metastatic nonsquamous non-small cell lung cancer; Recurrent, IV-B Cervical cancer; Unresectable Thymoma",DHFR; GART; TYMS; ATIC; FOLR3; SLC46A1; MTHFR; GGH; KRAS; ALK; SLC19A1,14/11/2022,CHEMBL225072,,,,
Pemigatinib,Y,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB15102"">DB15102</a>",L01EN02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297522"">CHEMBL4297522</a>","Unresectable, locally advanced Cholangiocarcinomas; Unresectable, metastatic Cholangiocarcinomas",FGFR2; FGFR1; FGFR3,1/2/2022,CHEMBL4297522,,,,
Pentostatin,N,N,Y,,N,1991,Y,"<a href=""https://go.drugbank.com/drugs/DB00552"">DB00552</a>",L01XX08,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1580"">CHEMBL1580</a>","B-Lymphocytic, prolymphocytic leukemia (Kiel Classification) refractory; Chronic Lymphocytic Leukaemia (CLL); Hairy Cell Leukemia (HCL); Mycosis Fungoides (MF); Sezary Syndrome",ADA; PRKAA1,22/09/2020,CHEMBL1580,,,,
Pertuzumab,Y,Y,N,,N,2012,N,"<a href=""https://go.drugbank.com/drugs/DB06366"">DB06366</a>",L01FD02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2007641"">CHEMBL2007641</a>",Early Breast Cancer; Inflammatory Breast Cancer (IBC); Locally Advanced Breast Cancer (LABC); Metastatic Breast Cancer,ERBB2; PGR; NRG1; ESR2; PIK3CA; BRAF; ERBB3,1/2/2022,CHEMBL2007641,,,,
Pipobroman,N,N,Y,,N,1966,,"<a href=""https://go.drugbank.com/drugs/DB00236"">DB00236</a>",L01AX02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1585"">CHEMBL1585</a>",,,22/09/2020,CHEMBL1585,,,,
Pirarubicin,N,N,N,Japan,N,,,"<a href=""https://go.drugbank.com/drugs/DB11616"">DB11616</a>",L01DB08,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2354444"">CHEMBL2354444</a>",,KMT2A; GLS; ABCC1,1/2/2022,CHEMBL2354444,,,,
Pixantrone,Y,N,N,,N,2012,N,"<a href=""https://go.drugbank.com/drugs/DB06193"">DB06193</a>",L01DB11,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL167731"">CHEMBL167731</a>","Non-Hodgkin&#39;s Lymphoma, Relapsed; Refractory Non-Hodgkin&#39;s lymphoma",TOP2B,17/09/2020,CHEMBL167731,,,,
Polatuzumab Vedotin,Y,Y,N,,N,2019,N,"<a href=""https://go.drugbank.com/drugs/DB12240"">DB12240</a>",L01FX14,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301582"">CHEMBL3301582</a>",Diffuse Large B-Cell Lymphoma (DLBCL),CD79B,1/2/2022,CHEMBL3301582,,,,
Polyestradiol Phosphate,N,N,Y,,N,1957,,"<a href=""https://go.drugbank.com/drugs/DB09369"">DB09369</a>",L02AA02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201477"">CHEMBL1201477</a>",,ESR1,22/09/2020,CHEMBL1201477,,,,
Pomalidomide,Y,Y,N,,N,2013,N,"<a href=""https://go.drugbank.com/drugs/DB08910"">DB08910</a>",L04AX06,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL43452"">CHEMBL43452</a>",Refractory Multiple Myeloma,CRBN; CUL4A; DDB1; RBX1,17/09/2020,CHEMBL43452,,,,
Ponatinib,Y,Y,N,,N,2012,N,"<a href=""https://go.drugbank.com/drugs/DB08901"">DB08901</a>",L01EA05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1171837"">CHEMBL1171837</a>",Accelerated phase chronic myologenic leukemia; Acute Lymphoblastic Leukaemias (ALL); Chronic Phase Chronic Myeloid Leukemia; Blast phase Chronic myelocytic leukemia,FGFR4; RET; FLT3; FGFR3; FGFR1; SRC; FGFR2; PDGFRA; BCR; ABL1; KIT; PDGFRB; ABI1; ABL2,22/06/2022,CHEMBL1171837,,,,
Porfimer,Y,Y,N,,N,1995,N,"<a href=""https://go.drugbank.com/drugs/DB00707"">DB00707</a>",L01XD01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201481"">CHEMBL1201481</a>",Esophageal Cancers; Completely obstructive Non-small cell lung cancer; Microinvasive endobrachial Non-small cell lung cancer; Partially obstructive Non-small cell lung cancer,,17/09/2020,CHEMBL1201481,,,,
Pralatrexate,Y,Y,N,,N,2009,N,"<a href=""https://go.drugbank.com/drugs/DB06813"">DB06813</a>",L01BA05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201746"">CHEMBL1201746</a>",Cutaneous T-Cell Lymphoma (CTCL); Relapsed Peripheral T-Cell Lymphoma; Refractory Peripheral T-cell Lymphoma Unspecified,DHFR; PDF; RFC1,17/09/2020,CHEMBL1201746,,,,
Pralsetinib,Y,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB15822"">DB15822</a>",L01EX23,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297597"">CHEMBL4297597</a>",Metastatic RET-fusion Non Small Cell Lung Cancer,RET,22/06/2022,CHEMBL4297597,,,,
Prednisolone,Y,Y,N,,Y,1955,Y,"<a href=""https://go.drugbank.com/drugs/DB00860"">DB00860</a>",S03BA02; S02BA03; S01CB02; S01BA04; R01AD02; H02AB06; D07XA02; D07AA03; C05AA04; A07EA01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL131"">CHEMBL131</a>","Hypercalcemia of Malignancy; Leukemia, Acute; Malignant Lymphomas; Mycosis Fungoides (MF)",NR3C1; ANXA1; RB1; FCGR3B; TAT; PNPLA3; BAX; NOTCH1; TG; CD34; PLG; ALPP; LOH19CR1; FCGR3A; LCAT; DSE; BGLAP; TSPYL1; HMGB1,14/11/2022,CHEMBL131,,,,
Prednisone,N,Y,Y,,N,1955,Y,"<a href=""https://go.drugbank.com/drugs/DB00635"">DB00635</a>",H02AB07; A07EA03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL635"">CHEMBL635</a>","Acute Lymphoblastic Leukaemias (ALL); Aggressive Lymphoma; Hypercalcemia of Malignancy; Leukemia, Acute; Leukemias; Malignant Lymphomas; Metastatic Castration Resistant Prostate Cancer; Mycosis Fungoides (MF)",NR3C1; TPMT; ANXA1; PTPRC; VWF; TG; DROSHA; CTLA4; GSTM1; LINC00251; BMP7; MC2R; CALCA; TYMSOS; APOE; DOK5; ITGB2; IFNG; GATA3; GSTA1; MBP; CXCL12,14/11/2022,CHEMBL635,,,,
Procarbazine,N,Y,Y,,Y,1969,N,"<a href=""https://go.drugbank.com/drugs/DB01168"">DB01168</a>",L01XB01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1321"">CHEMBL1321</a>",Non-Hodgkin&#39;s Lymphoma (NHL); Oligodendrogliomas; Primary Central Nervous System Lymphoma (PCNSL); Stage III Hodgkin&#39;s Disease; Stage IV Hodgkin&#39;s Disease,BAX; CSF2; ATRX,17/09/2020,CHEMBL1321,,,,
Racotumomab,N,N,N,"Cuba, Argentina",N,,,"<a href=""https://go.drugbank.com/drugs/DB13045"">DB13045</a>",,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743059"">CHEMBL1743059</a>",,,17/09/2020,CHEMBL1743059,,,,
Radium 223 Dichloride,Y,Y,N,,N,2013,N,"<a href=""https://go.drugbank.com/drugs/DB08913"">DB08913</a>",V10XX03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107816"">CHEMBL2107816</a>","Castration resistant, metastatic Prostate cancer",,17/09/2020,CHEMBL2107816,,,,
Raltitrexed,N,N,Y,Canada,N,1996,N,"<a href=""https://go.drugbank.com/drugs/DB00293"">DB00293</a>",L01BA03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL225071"">CHEMBL225071</a>",Advanced Colorectal Cancer; Pleural Mesotheliomas,TYMS; ALB; CDKN1B; CDK2; DHFR; BCL2; SLC19A1,17/09/2020,CHEMBL225071,,,,
Ramucirumab,Y,Y,N,,N,2014,N,"<a href=""https://go.drugbank.com/drugs/DB05578"">DB05578</a>",L01FG02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743062"">CHEMBL1743062</a>","Advanced Gastric Cancer; Advanced gastro-esophageal junction adenocarcinoma; Refractory, metastatic Colorectal cancer; Refractory, metastatic Non small cell lung cancer",KDR; PDGFRA; KRAS; EGFR; ERBB2; ALK,1/2/2022,CHEMBL1743062,,,,
Ranimustine,N,N,N,Japan,N,,,"<a href=""https://go.drugbank.com/drugs/DB13832"">DB13832</a>",L01AD07,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105348"">CHEMBL2105348</a>",,,22/09/2020,CHEMBL2105348,,,,
Regorafenib,Y,Y,N,,N,2012,N,"<a href=""https://go.drugbank.com/drugs/DB08896"">DB08896</a>",L01EX05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1946170"">CHEMBL1946170</a>",Hepatocellular Carcinoma; Metastatic Colorectal Cancer (MCRC); Metastatic Gastrointestinal Stromal Tumor; Locally advanced Gastrointestinal stromal tumor; Unresectable Gastrointestinal stromal tumor,RAF1; FLT1; BRAF; DDR2; PDGFRA; FLT4; PDGFRB; KRAS; KIT; RET; TEK; FRK; KDR; MAPK11; EPHA2; ARAF; VHL; FBXW7; APC; NRAS,1/2/2022,CHEMBL1946170,,,,
Relatlimab  Nivolumab,Y,Y,N,,N,2022,,"<a href=""https://go.drugbank.com/drugs/DB14851"">DB14851</a>",L01XY03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3990044"">CHEMBL3990044</a>","Metastatic Melanoma, Unresectable Melanoma",LAG3,14/11/2022,CHEMBL3990044,,,,
Relugolix,Y,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB11853"">DB11853</a>",L02BX04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1800159"">CHEMBL1800159</a>",Advanced Prostate Cancer,GNRHR; LHCGR,31/01/2022,CHEMBL1800159,,,,
Ribociclib,Y,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB11730"">DB11730</a>",L01EF02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545110"">CHEMBL3545110</a>",Advanced Breast Cancer; Metastatic Breast Cancer,CDK6; CDK4; CCND2; NRAS; RB1; CCND1; CDKN2A; SMARCA4; CCND3; NOTCH1; PGR,1/2/2022,CHEMBL3545110,,,,
Ripretinib,Y,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB14840"">DB14840</a>",L01EX19,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4216467"">CHEMBL4216467</a>",Advanced Gastrointestinal Stromal Tumor (GIST),KIT; PDGFRA,30/09/2021,CHEMBL4216467,,,,
Rituximab,Y,Y,N,,Y,1997,N,"<a href=""https://go.drugbank.com/drugs/DB00073"">DB00073</a>",L01FA01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201576"">CHEMBL1201576</a>",Chronic Lymphocytic Leukaemia (CLL); Non-Hodgkin&#39;s Lymphoma (NHL),MS4A1; FCGR2A; IL2; TGFB1; IL10; IL6; GSTA1; CXCL13; FCGR3A; LOH19CR1; XIAP; CXCL12,1/2/2022,CHEMBL1201576,,,,
"Rituximab, Hyaluronidase",N,Y,N,,N,1997,N,"<a href=""https://go.drugbank.com/drugs/DB00073"">DB00073</a>",L01XC02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201576"">CHEMBL1201576</a>",Chronic Lymphocytic Leukaemia (CLL); Non-Hodgkin&#39;s Lymphoma (NHL),MS4A1; FCGR2A; IL2; TGFB1; IL10; IL6; GSTA1; CXCL13; FCGR3A; LOH19CR1; XIAP; CXCL12,17/09/2020,CHEMBL1201576,,,,
Romidepsin,Y,Y,N,,N,2009,Y,"<a href=""https://go.drugbank.com/drugs/DB06176"">DB06176</a>",L01XH02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL343448"">CHEMBL343448</a>",Refractory peripheral cutaneous T-cell lymphoma,HDAC1; HDAC3; HDAC4; HDAC9; HDAC2; HDAC6; HDAC8; HDAC5; HDAC10; HDAC7; HDAC11; MCL1; CDKN2D; CDKN1A; CTAG1B; KMT2A; BIRC5,1/2/2022,CHEMBL343448,,,,
Rucaparib,Y,Y,N,,N,2016,N,"<a href=""https://go.drugbank.com/drugs/DB12332"">DB12332</a>",L01XK03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1173055"">CHEMBL1173055</a>",Advanced Ovarian Cancer,PARP3; PARP1; PARP2; PALB2; STAG2; SLC47A1; BRCA2; SLC22A6; ATR; SLC22A8; SLC47A2; BRCA1,1/2/2022,CHEMBL1173055,,,,
Ruxolitinib,Y,Y,N,,N,2011,N,"<a href=""https://go.drugbank.com/drugs/DB08877"">DB08877</a>",L01EJ01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1789941"">CHEMBL1789941</a>",Post Polycythemia Vera Myelofibrosis; Refractory Polycythemia vera,JAK2; JAK3; JAK1; VHL; MPL; CRLF2; CSF3R; PLAUR,22/06/2022,CHEMBL1789941,,,,
Sacituzumab Govitecan,Y,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB12893"">DB12893</a>",L01FX17,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545262"">CHEMBL3545262</a>",Metastatic Triple-negative Breast Cancer,,31/01/2022,CHEMBL3545262,,,,
Selinexor,Y,Y,N,,N,2019,N,"<a href=""https://go.drugbank.com/drugs/DB11942"">DB11942</a>",L01XX66,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3545185"">CHEMBL3545185</a>",Refractory Multiple Myeloma,XPO1,10/3/2021,CHEMBL3545185,,,,
Selpercatinib,Y,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB15685"">DB15685</a>",L01EX22,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4559134"">CHEMBL4559134</a>",Advanced RET-fusion thyroid cancer; Advanced RET-mutant medullary thyroid cancer; Metastatic RET-fusion Non Small Cell Lung Cancer; Metastatic RET-fusion thyroid cancer; Metastatic RET-mutant medullary thyroid cancer,,1/2/2022,CHEMBL4559134,,,,
Sipuleucel-T,N,Y,N,,N,2010,N,"<a href=""https://go.drugbank.com/drugs/DB06688"">DB06688</a>",L03AX17,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1237024"">CHEMBL1237024</a>","Asymptomatic, metastatic hormone-refractory Prostate cancer; Minimally symptomatic, metastatic hormone-refractory Prostate cancer",,17/09/2020,CHEMBL1237024,,,,
Sonidegib,Y,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB09143"">DB09143</a>",L01XJ02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105737"">CHEMBL2105737</a>","Refractory, locally advanced Basal cell carcinoma",SMO; MYCN; SUFU; PTCH1; EGFR,1/2/2022,CHEMBL2105737,,,,
Sorafenib,Y,Y,N,,N,2005,Y,"<a href=""https://go.drugbank.com/drugs/DB00398"">DB00398</a>",L01EX02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1336"">CHEMBL1336</a>",Advanced Renal Cell Carcinoma; Gastrointestinal Stromal Tumors; Hemangiosarcoma; Unresectable Hepatocellular Carcinoma; Locally recurrent refractory to radioactive iodine treatment Thyroid carcinoma; Metastatic refractory to radioactive iodine treatment Thyroid carcinoma,KDR; FLT3; RET; BRAF; RAF1; FLT4; PDGFRB; KIT; ARAF; HMOX1; UGT1A9; MAPK6; SLC15A2; FGF3; GALNT14; PTPN6; MAPK4; SLC22A1; MAPK7; ARID1A,14/11/2022,CHEMBL1336,,,,
Sotorasib,Y,Y,N,,N,2021,N,"<a href=""https://go.drugbank.com/drugs/DB15569"">DB15569</a>",L01XX73,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4535757"">CHEMBL4535757</a>","Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer",,1/2/2022,CHEMBL4535757,,,,
Streptozocin,N,Y,N,,N,2005,N,"<a href=""https://go.drugbank.com/drugs/DB00428"">DB00428</a>",L01AD04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1603"">CHEMBL1603</a>; <a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1651906"">CHEMBL1651906</a>",Stage 4 islet cell carcinoma,SLC2A4; SULT1A2; ADCYAP1; SLC2A5; IGFBP1; ATF2; VWF; S100B; HGF; SSTR1; GALP; SLC16A3; PRKAA1; THRSP; ACP5; SFTPB; ENO2; DDIT3; RAMP3; PREP; CYP7B1; MMP2; OGA; MYO9B; KCNA2; KCNJ11; TH; SI; UCP1; SST; CDKN1B; MT1H; CD40; HP; PTGER4; LCAT; CTSD; SLC5A1,1/2/2022,CHEMBL1603,,,,CHEMBL1651906</a
Sunitinib,Y,Y,N,,N,2006,Y,"<a href=""https://go.drugbank.com/drugs/DB01268"">DB01268</a>",L01EX01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL535"">CHEMBL535</a>","Advanced Renal Cell Carcinoma; Soft Tissue Sarcoma (STS); Thyroid Cancers; Metastatic Pancreatic Neuroendocrine Tumors; Refractory Gastrointestinal stromal tumor; Unresectable, locally advanced Pancreatic Neuroendocrine Tumors",PDGFB; PDGFC; PDGFRB; FLT4; FLT3; CSF1R; PDGFD; KIT; KDR; FLT1; PDGFA; RET; PDGFRA; PTPRB; NOS3; HMOX1; VHL; ABCG2; PBRM1; VEGFC; SLCO1B3; EWSR1; BAP1; NR1I3; POR; PTPN12; IL13; KDM5C,14/11/2022,CHEMBL535,,,,
Tafasitamab,Y,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB15044"">DB15044</a>",L01FX12,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4298047"">CHEMBL4298047</a>",Refractory Diffuse large B-cell lymphoma NOS; Relapsed Diffuse large B-cell lymphoma NOS,TNFRSF8,1/2/2022,CHEMBL4298047,,,,
Tagraxofusp,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB14731"">DB14731</a>",L01XX67,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297573"">CHEMBL4297573</a>",Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN),IL3RA; CSF2RB,16/07/2021,CHEMBL4297573,,,,
Talazoparib,Y,Y,N,,N,2018,N,"<a href=""https://go.drugbank.com/drugs/DB11760"">DB11760</a>",L01XK04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3137320"">CHEMBL3137320</a>",Locally Advanced Breast Cancer (LABC); Metastatic Breast Cancer,PARP2; PARP1; ATM; PTEN; SLFN11; BRCA1; PSMD4; BRCA2,1/2/2022,CHEMBL3137320,,,,
Talimogene Laherparepvec,Y,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB13896"">DB13896</a>",L01XX51,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2108727"">CHEMBL2108727</a>",Unresectable Skin Lesion,,17/09/2020,CHEMBL2108727,,,,
Tamoxifen,N,Y,Y,,Y,1977,Y,"<a href=""https://go.drugbank.com/drugs/DB00675"">DB00675</a>",L02BA01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL83"">CHEMBL83</a>",Breast Cancer; Desmoid Tumors; Endometrial Cancer; Invasive Breast Cancer; Invasive Breast Carcinoma; Metastatic Breast Cancer; Ovarian Cancer,ESR2; ESR1; KLK3; GGT1; FMO1; NCOA1; TGM2; PLD1; E2F7; CCND1; PLD2; GAPDH; EDN1; PIP; CETP; LRMDA; F5; HEXB; HSPB2; CCNA2; PGR; MUC16; COL18A1; MYOD1; NCOA3; TFF3; ZNF423; RRAS2; FMO3; DHFR,22/06/2022,CHEMBL83,,,,
Tazemetostat,N,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB12887"">DB12887</a>",L01XX72,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3414621"">CHEMBL3414621</a>",Locally Advanced Epithelioid Sarcoma; Metastatic Epithelioid Sarcoma,EZH2; SMARCB1; SMARCA4; KRAS; KDM6A,1/2/2022,CHEMBL3414621,,,,
Tebentafusp,Y,Y,N,,N,2022,N,"<a href=""https://go.drugbank.com/drugs/DB15283"">DB15283</a>",L01XX75,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297990"">CHEMBL4297990</a>","Metastatic Uveal Melanoma (UM), Unresectable Uveal Melanoma",PMEL; TRBV20OR9-2; CD3G,23/10/2022,CHEMBL4297990,,,,
Teclistamab,Y,N,N,,N,2022,N,"<a href=""https://go.drugbank.com/drugs/DB16655"">DB16655</a>",,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4594505"">CHEMBL4594505</a>",Multiple Myeloma,,23/10/2022,CHEMBL4594505,,,,
"Tegafur, Gimeracil, Oteracil",Y,N,N,,N,2011,,"<a href=""https://go.drugbank.com/drugs/DB09256"">DB09256</a>",L01BC03; L01BC53,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL20883"">CHEMBL20883</a>",Advanced Gastric Cancer,TYMS; UMPS; DPYD; EGFR,1/2/2022,CHEMBL20883,,,,
"Tegafur, Uracil",N,N,N,Japan,N,,,"<a href=""https://go.drugbank.com/drugs/DB09256"">DB09256</a>",L01BC03; L01BC53,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL20883"">CHEMBL20883</a>",Advanced Gastric Cancer,TYMS; UMPS; DPYD; EGFR,1/2/2022,CHEMBL20883,,,,
Temoporfin,Y,N,N,,N,2001,N,"<a href=""https://go.drugbank.com/drugs/DB11630"">DB11630</a>",L01XD05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL500576"">CHEMBL500576</a>",Advanced Head and Neck Squamous Cell Carcinoma,,17/09/2020,CHEMBL500576,,,,
Temozolomide,Y,Y,N,,N,1999,Y,"<a href=""https://go.drugbank.com/drugs/DB00853"">DB00853</a>",L01AX03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL810"">CHEMBL810</a>","Advanced Melanoma; Glioblastomas; Primary Central Nervous System Lymphoma (PCNSL); Refractory Ewing Sarcoma; Refractory Neuroblastoma; Soft Tissue Sarcoma (STS); Advanced Neuroendocrine tumor; Refractory Anaplastic astrocytoma; Refractory, advanced Mycosis fungoides; Refractory, advanced Sezary Syndrome",SLFN11; HDAC4; CSF2; PRL; STAG2; ATRX; ATM; H2AX; MGMT; NOTCH1; BRCA2; MSH6,14/11/2022,CHEMBL810,,,,
Temsirolimus,Y,Y,N,,N,2007,Y,"<a href=""https://go.drugbank.com/drugs/DB06287"">DB06287</a>",L01EG01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201182"">CHEMBL1201182</a>",Advanced Renal Cell Carcinoma,MTOR; BRAF; FKBP1A; CTNNB1; NF2; PIK3CA; PTEN; VHL; FBXW7; KRAS; AKT1,1/2/2022,CHEMBL1201182,,,,
Tepotinib,Y,Y,N,,N,2021,N,"<a href=""https://go.drugbank.com/drugs/DB15133"">DB15133</a>",L01EX21,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3402762"">CHEMBL3402762</a>",Metastatic Non-Small Cell Lung Cancer,MET,31/01/2022,CHEMBL3402762,,,,
Thalidomide,Y,Y,N,,Y,1998,N,"<a href=""https://go.drugbank.com/drugs/DB01041"">DB01041</a>",L04AX02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL468"">CHEMBL468</a>",Multiple Myeloma (MM); Waldenstrom&#39;s Macroglobulinemia (WM); Treatment naive multiple myeloma,RBX1; CRBN; CUL4A; DDB1; TNF; PTGS2; FGFR2; SPG7; XRCC5; GSTT1; CYP4B1; CTLA4; CHST3; ITGB2; ATP7A; FGF2; CTNNB1; F2R; ABCC6; VWF; RPL13; HGF; NAT2; SULT1C4; ERCC1; HLA-B; IL6R; FCGR3B; SLC10A2; FCGR3A; SNORD68,1/2/2022,CHEMBL468,,,,
Thiotepa,Y,Y,N,,N,1959,Y,"<a href=""https://go.drugbank.com/drugs/DB04572"">DB04572</a>",L01AC01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL671"">CHEMBL671</a>",Adenocarcinoma of the Ovaries; Breast Adenocarcinoma; Papillary transitional cell carcinoma of bladder; Malignant effusion,CYP2B6; GSTP1,14/11/2022,CHEMBL671,,,,
Tioguanine,N,Y,N,,Y,1966,N,"<a href=""https://go.drugbank.com/drugs/DB00352"">DB00352</a>",L01BB03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL727"">CHEMBL727</a>",Acute Nonlymphocytic Leukemia; Nonlymphocytic Acute myeloid leukemia,IMPDH2; IMPDH1; DOK5; GGH; TPM3; MGMT; NUDT15; PRPS1; LINC00251; GDA; TPMT; NT5C2; GATA3; ACHE; ABCC4; MYC; BMP7,1/2/2022,CHEMBL727,,,,
Tisagenlecleucel,Y,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB13881"">DB13881</a>",L01XX71,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301574"">CHEMBL3301574</a>",Refractory B-cell precursor acute lymphoblastic leukemia; Second or later relapsed B-cell precursor acute lymphoblastic leukemia,CD19; MS4A1,17/09/2020,CHEMBL3301574,,,,
Tivozanib,Y,Y,N,,N,2017,N,"<a href=""https://go.drugbank.com/drugs/DB11800"">DB11800</a>",L01EK03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1289494"">CHEMBL1289494</a>",Advanced Renal Cell Carcinoma; Renal Cell Adenocarcinoma,FLT1; FLT4; KDR; BRAF; ERBB2,1/2/2022,CHEMBL1289494,,,,
Topotecan,Y,Y,N,,N,1996,Y,"<a href=""https://go.drugbank.com/drugs/DB01030"">DB01030</a>",L01CE01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL84"">CHEMBL84</a>","Acute Myeloid Leukemia (AML); Ewing&#39;s Sarcoma; Refractory Neuroblastoma; Metastatic Rhabdomyosarcoma; Recurrent, IV-B Cervical cancer; Refractory CNS lymphoma; Refractory CNS malignancy; Refractory, metastatic Ovarian cancer; Relapsed Small cell lung cancer",TOP1MT; TOP1; TYMS; ATRX; BDNF; RB1; MUC16; ALK; DDO; AKT1; ABCG2,1/2/2022,CHEMBL84,,,,
Toremifene,Y,Y,N,,N,1997,Y,"<a href=""https://go.drugbank.com/drugs/DB00539"">DB00539</a>",L02BA02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1655"">CHEMBL1655</a>",Desmoid Tumors; Metastatic Breast Cancer,ESR1; ESR2; PGR; CYP1B1; TGFB1; CD80,17/09/2020,CHEMBL1655,,,,
Trabectedin,Y,Y,N,,N,2015,N,"<a href=""https://go.drugbank.com/drugs/DB05109"">DB05109</a>",L01CX01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL450449"">CHEMBL450449</a>",Metastatic Leiomyosarcoma; Metastatic Liposarcoma; Relapsed platinum-sensitive Ovarian cancer; Unresectable Leiomyosarcoma; Unresectable Liposarcoma,FGFR2; ABCB1; PARP1,1/2/2022,CHEMBL450449,,,,
Trametinib,Y,Y,N,,N,2013,N,"<a href=""https://go.drugbank.com/drugs/DB08911"">DB08911</a>",L01EE01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2103875"">CHEMBL2103875</a>",Metastatic Melanoma; Unresectable Melanoma,MAP2K3; MAP2K1; MAP2K6; MAP2K4; MAP2K5; MAP2K2; MAP2K7; GNA11; ARAF; ATXN1L; ETV5; ETV4; ETV1; NF1; NRAS; DDX43; STAG2; BRAF; STK11; CDKN2A; DUSP6; RB1; KRAS; RASA1; RAF1; ERBB3; CIC; GNAQ; HRAS; VHL; CTNNB1,1/2/2022,CHEMBL2103875,,,,
Trastuzumab,Y,Y,N,,Y,1998,N,"<a href=""https://go.drugbank.com/drugs/DB00072"">DB00072</a>",L01FD01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201585"">CHEMBL1201585</a>",Breast Cancer; Early Breast Cancer; Inflammatory Breast Cancer (IBC); Locally Advanced Breast Cancer (LABC); Metastatic Adenocarcinoma of the Gastro-Esophageal Junction; Metastatic Adenocarcinoma of the Stomach; Metastatic Breast Cancer; Metastatic Gastric Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma,ERBB2; AKT2; FCGR2A; IFNG; FCGR3A; RNF8; BARD1; BIRC5; ERBB3; APC; PPCDC; PIK3CA; EPCAM; PGR; PTEN,1/2/2022,CHEMBL1201585,,,,
Trastuzumab Deruxtecan,Y,Y,N,,N,2019,N,"<a href=""https://go.drugbank.com/drugs/DB14962"">DB14962</a>",L01FD04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297844"">CHEMBL4297844</a>",HER2 Positive Breast Cancers,ERBB2,1/2/2022,CHEMBL4297844,,,,
Trastuzumab Emtansine,Y,Y,N,,N,2013,N,"<a href=""https://go.drugbank.com/drugs/DB05773"">DB05773</a>",L01FD03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1743082"">CHEMBL1743082</a>","Refractory, metastatic Non small cell lung cancer",TUBA1A; TUBB8; TUBB3; TUBB2A; TUBA3E; TUBA4A; TUBA3D; TUBA1C; TUBB6; TUBB4B; TUBA1B; TUBB2B,1/2/2022,CHEMBL1743082,,,,
"Trastuzumab, Hyaluronidase",Y,Y,N,,N,1998,N,"<a href=""https://go.drugbank.com/drugs/DB00072"">DB00072</a>",L01XC03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201585"">CHEMBL1201585</a>",Breast Cancer; Early Breast Cancer; Inflammatory Breast Cancer (IBC); Locally Advanced Breast Cancer (LABC); Metastatic Adenocarcinoma of the Gastro-Esophageal Junction; Metastatic Adenocarcinoma of the Stomach; Metastatic Breast Cancer; Metastatic Gastric Adenocarcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma,ERBB2; AKT2; FCGR2A; IFNG; FCGR3A; RNF8; BARD1; BIRC5; ERBB3; APC; PPCDC; PIK3CA; EPCAM; PGR; PTEN,1/2/2022,CHEMBL1201585,,,,
Tretinoin,N,Y,Y,,N,1971,Y,"<a href=""https://go.drugbank.com/drugs/DB00755"">DB00755</a>",D10AD01; L01XF01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL38"">CHEMBL38</a>",FAB classification M3 Acute promyelocytic leukemia,RXRB; RARG; RXRG; RARRES1; RARA; RARB; MYCN; FUS; CDKN1B; BCL2; PML; BCOR; NPM1; HSPA8; P2RY2; BIRC5; SMAD2; FLT3; IL10,14/11/2022,CHEMBL38,,,,
"Trifluridine, Tipiracil",Y,Y,N,,N,1980,Y,"<a href=""https://go.drugbank.com/drugs/DB00432"">DB00432</a>",L01BC59; S01AD02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1129"">CHEMBL1129</a>",Metastatic Colorectal Cancer (MCRC),ERBB2; TP53; SLC29A1,1/2/2022,CHEMBL1129,,,,
Triptorelin,N,Y,Y,,N,2000,N,"<a href=""https://go.drugbank.com/drugs/DB06825"">DB06825</a>",L02AE04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201334"">CHEMBL1201334</a>",Advanced Prostate Cancer,GNRHR; STS,17/09/2020,CHEMBL1201334,,,,
Trofosfamide,N,N,Y,,N,,,"<a href=""https://go.drugbank.com/drugs/DB12902"">DB12902</a>",L01AA07,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL462019"">CHEMBL462019</a>",,CYP2B6,22/09/2020,CHEMBL462019,,,,
Tucatinib,Y,Y,N,,N,2020,N,"<a href=""https://go.drugbank.com/drugs/DB11652"">DB11652</a>",L01EH03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3989868"">CHEMBL3989868</a>",Breast Cancer; Unresectable Breast Cancer,ERBB2,22/06/2022,CHEMBL3989868,,,,
Umbralisib,N,Y,N,,N,2021,N,"<a href=""https://go.drugbank.com/drugs/DB14989"">DB14989</a>",L01EX25,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3948730"">CHEMBL3948730</a>",B-cell Follicular Lymphoma; Marginal Zone Lymphoma (MZL),,23/10/2022,CHEMBL3948730,,,,
Valrubicin,N,Y,N,,N,1998,Y,"<a href=""https://go.drugbank.com/drugs/DB00385"">DB00385</a>",L01DB09,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1096885"">CHEMBL1096885</a>",In situ BCG-refractory Bladder carcinoma,TOP2A; TOP2B,17/09/2020,CHEMBL1096885,,,,
Vandetanib,Y,Y,N,,N,2011,N,"<a href=""https://go.drugbank.com/drugs/DB05294"">DB05294</a>",L01EX04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL24828"">CHEMBL24828</a>",Metastatic Medullary Thyroid Cancer; Locally advanced Medullary thyroid cancer,EPHB1; EGFR; EPHA4; KDR; RET; EPHB3; EPHA5; EPHA8; EPHB4; PTK6; EPHB2; EPHA1; EPHA10; EPHB6; EPHA3; EPHA7; EPHA6; APC,1/2/2022,CHEMBL24828,,,,
Vemurafenib,Y,Y,N,,N,2011,N,"<a href=""https://go.drugbank.com/drugs/DB08881"">DB08881</a>",L01EC01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1229517"">CHEMBL1229517</a>",Metastatic Melanoma; Unresectable Melanoma; Refractory Non-small cell lung cancer,BRAF; PREX2; CIC; CDKN2A; STAG3; AKT3; MAP2K1; MAP2K2; PTEN; STAG2; PIK3R2; NRAS; NF1; ATXN1L; RAC1; SOX10,1/2/2022,CHEMBL1229517,,,,
Venetoclax,Y,Y,N,,N,2016,N,"<a href=""https://go.drugbank.com/drugs/DB11581"">DB11581</a>",L01XX52,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3137309"">CHEMBL3137309</a>",Chronic Lymphocytic Leukaemia (CLL); Small Lymphocytic Lymphoma,BCL2; FLT3; NPM1; BRAF; IGH; PTEN; IDH2,22/06/2022,CHEMBL3137309,,,,
Vinblastine,N,Y,Y,,Y,1965,Y,"<a href=""https://go.drugbank.com/drugs/DB00570"">DB00570</a>",L01CA01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL159"">CHEMBL159</a>","Advanced Soft Tissue Sarcoma; Cancer, Bladder; Kaposi&#39;s sarcoma; Lymphoma, Hodgkins; Metastatic Melanoma; Non-Small Cell Lung Carcinoma (NSCLC); Advanced Alibert-Bazin syndrome; Advanced Testicular cancer; Histiocytic lymphoma; Refractory Breast cancer",TUBB; TUBA1A; TUBA3C; TUBB1; TUBB2A; TUBB2B; KLK3; CGA; GSTM1; ABCB4; TUBA1B; TUBA3E; TRH; TUBA1C; CDKN1A; TBXA2R; TUBB4B; TUBB3; TUBB4A; MMP2; PTHLH; TUBA4A; TUBB8; TUBB6; TUBA3D; CSF2,1/2/2022,CHEMBL159,,,,
Vincristine,N,Y,Y,,Y,1965,Y,"<a href=""https://go.drugbank.com/drugs/DB00541"">DB00541</a>",L01CA02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL499458"">CHEMBL499458</a>; <a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL90555"">CHEMBL90555</a>","Acute Lymphoblastic Leukaemia Recurrent; Acute Lymphocytic Leukemia (ALL); Choriocarcinoma; Chronic Lymphocytic Leukaemia (CLL); Ewing&#39;s Sarcoma; Hepatoblastomas; Kaposi&#39;s sarcoma; Lymphoma, Hodgkins; Multiple Myeloma (MM); Neuroblastomas; Non-Hodgkin&#39;s Lymphoma (NHL); Ovarian germ cell tumour; Pheochromocytomas; Retinoblastoma; Rhabdomyosarcomas; Small Cell Lung Cancer (SCLC); Wilms&#39; tumor; Advanced Thymoma",TUBB; TUBA4A; TUBA3E; CXCL12; LINC00251; TUBB2B; BCR; TUBB3; TUBA3D; FGF2; ABCC10; CDKN1B; GATA3; AFP; TUBB4B; CEP72; TUBA1B; TUBA3C; BMP7; ODC1; DROSHA; DOK5; CP; PNPLA3; TUBA1C; TUBB6; TUBA1A; MYCN; NTF3; TUBB4A; GSTA1; ABCB4; RALBP1; TUBB2A; ACTG1; VWF; ATRX; SRI; TUBB8; CAPG,1/2/2022,CHEMBL499458,,,,CHEMBL90555</a
Vincristine Liposome,N,Y,N,,N,2012,Y,"<a href=""https://go.drugbank.com/drugs/DB00541"">DB00541</a>",L01CA02,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL499458"">CHEMBL499458</a>; <a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL90555"">CHEMBL90555</a>","Acute Lymphoblastic Leukaemia Recurrent; Acute Lymphocytic Leukemia (ALL); Choriocarcinoma; Chronic Lymphocytic Leukaemia (CLL); Ewing&#39;s Sarcoma; Hepatoblastomas; Kaposi&#39;s sarcoma; Lymphoma, Hodgkins; Multiple Myeloma (MM); Neuroblastomas; Non-Hodgkin&#39;s Lymphoma (NHL); Ovarian germ cell tumour; Pheochromocytomas; Retinoblastoma; Rhabdomyosarcomas; Small Cell Lung Cancer (SCLC); Wilms&#39; tumor; Advanced Thymoma",TUBB; TUBA4A; TUBA3E; CXCL12; LINC00251; TUBB2B; BCR; TUBB3; TUBA3D; FGF2; ABCC10; CDKN1B; GATA3; AFP; TUBB4B; CEP72; TUBA1B; TUBA3C; BMP7; ODC1; DROSHA; DOK5; CP; PNPLA3; TUBA1C; TUBB6; TUBA1A; MYCN; NTF3; TUBB4A; GSTA1; ABCB4; RALBP1; TUBB2A; ACTG1; VWF; ATRX; SRI; TUBB8; CAPG,1/2/2022,CHEMBL499458,,,,CHEMBL90555</a
Vindesine,N,N,Y,,N,1979,N,"<a href=""https://go.drugbank.com/drugs/DB00309"">DB00309</a>",L01CA03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL238071"">CHEMBL238071</a>","Acute Lymphocytic Leukemia (ALL); Melanoma, Malignant",TUBB1; ABCB1; TUBB,1/2/2022,CHEMBL238071,,,,
Vinflunine,Y,N,N,,N,2009,N,"<a href=""https://go.drugbank.com/drugs/DB11641"">DB11641</a>",L01CA05,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110725"">CHEMBL2110725</a>",Transitional Cell Carcinoma of the Urothelial Tract; Metastatic Transitional Cell Carcinoma of the Urothelial Tract,TUBA3E; TUBA3D; TUBB; TUBB3; TUBB2A; TUBA1C; TUBB6; TUBA1B; TUBA1A; TUBB4B; TUBA4A; TUBB2B; TUBB8,1/2/2022,CHEMBL2110725,,,,
Vinorelbine,N,Y,Y,,Y,1994,Y,"<a href=""https://go.drugbank.com/drugs/DB00361"">DB00361</a>",L01CA04,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL553025"">CHEMBL553025</a>","Advanced Non Small Cell Lung Cancer; Esophageal Cancers; Locally Advanced Non-Small Cell Lung Cancer; Metastatic Breast Cancer; Recurrent Cervical Cancer; Soft Tissue Sarcoma (STS); Recurrent, IV-B Cervical cancer",TUBB; TUB; SMARCA4; BAX; TUBB4B; TUBB3; TUBA3D; TUBB4A; CASP7; RRM1; TUBA1C; TUBB8; TUBB6; BRCA1; TUBA1A; TUBA3C; TUBA3E; TUBA4A; BRCA2; APC; TUBB2B; TUBA1B; XRCC1; TUBB2A,1/2/2022,CHEMBL553025,,,,
Vismodegib,Y,Y,N,,N,2012,N,"<a href=""https://go.drugbank.com/drugs/DB08828"">DB08828</a>",L01XJ01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL473417"">CHEMBL473417</a>",Locally Advanced Basal Cell Carcinoma; Metastatic Basal cell carcinoma,PTCH1; SMO; SHH,17/09/2020,CHEMBL473417,,,,
Vorinostat,N,Y,N,,N,2006,N,"<a href=""https://go.drugbank.com/drugs/DB02546"">DB02546</a>",L01XH01,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL98"">CHEMBL98</a>",Persistent Cutaneous T-Cell Lymphoma; Progressive Cutaneous T-cell lymphoma; Recurrent Cutaneous T-cell lymphoma,HDAC8; HDAC3; HDAC7; HDAC1; HDAC4; HDAC11; HDAC5; HDAC2; HDAC10; HDAC6; HDAC9; CFTR; NPM1; RB1; SMARCB1; FBXW7; TUBA3C; EZH2; MYD88; TUBB4A; BAP1; CHD4; NR0B1,1/2/2022,CHEMBL98,,,,
Zanubrutinib,Y,Y,N,,N,2019,N,"<a href=""https://go.drugbank.com/drugs/DB15035"">DB15035</a>",L01EL03,"<a href=""https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3936761"">CHEMBL3936761</a>",Mantle Cell Lymphoma (MCL),BTK,30/09/2021,CHEMBL3936761,,,,
